To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ICAM3_TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
737 representative clones for gene ICAM3_ back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG110432 Bone, osteosarcoma, cell line .a 1 to 657 657 to 1   tiling clone, Submitted on the opposite strand 657/657
(100 %)
6 diff
(99.1 %id)
AW662792 pooled .a 477 to 1034 1 to 558     Submitted on the opposite strand 558/558
(100 %)
21 diff
(96.3 %id)
AL137656 testis .a 479 to 3295 2817 to 1   tiling clone, available from DKFZ, Submitted on the opposite strand 2817/2880
(97 %)
3 diff
(99.9 %id)
AA922832 adenocarcinoma, colon .a 479 to 954 8 to 484     Submitted on the opposite strand 477/484
(98 %)
6 diff
(98.8 %id)
AI304561 adenocarcinoma, colon .a 479 to 909 7 to 438     Submitted on the opposite strand 432/438
(98 %)
7 diff
(98.5 %id)
AI653181 pooled germ cell tumors .a 479 to 802 23 to 347     Submitted on the opposite strand 325/358
(90 %)
6 diff
(98.4 %id)
AW136746   .a 479 to 964 13 to 498   tiling clone, Submitted on the opposite strand 486/498
(97 %)
6 diff
(98.8 %id)
AW204107   .a 479 to 716 13 to 250     Submitted on the opposite strand 238/255
(93 %)
4 diff
(98.5 %id)
AW206755   .a 479 to 852 13 to 386     Submitted on the opposite strand 374/386
(96 %)
6 diff
(98.5 %id)
TI_153990832   .a 479 to 941 84 to 546     Submitted on the opposite strand 463/546
(84 %)
6 diff
(99.0 %id)
AA974570 pooled .a 480 to 949 1 to 471     Submitted on the opposite strand 471/471
(100 %)
22 diff
(95.4 %id)
BE670428 carcinoid, lung .a 480 to 878 1 to 399     Submitted on the opposite strand 399/399
(100 %)
3 diff
(99.3 %id)
DB516983 testis .a 484 to 930 447 to 1       447/447
(100 %)
4 diff
(99.2 %id)
AI690006 carcinoid, lung .a 484 to 1054 1 to 569     Submitted on the opposite strand 569/576
(98 %)
10 diff
(98.3 %id)
AI701168 carcinoid, lung .a 484 to 1056 1 to 572     Submitted on the opposite strand 572/576
(99 %)
3 diff
(99.5 %id)
BE549750 carcinoid, lung .a 484 to 1035 1 to 552     Submitted on the opposite strand 552/552
(100 %)
1 diff
(99.9 %id)
DB517660 testis .a 493 to 937 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AW269982 pooled .a 497 to 1060 1 to 562     Submitted on the opposite strand 562/562
(100 %)
14 diff
(97.6 %id)
DB336453 testis .a 512 to 1106 1 to 595     Submitted on the opposite strand 595/595
(100 %)
3 diff
(99.5 %id)
BI828676 brain, medulla .a 2247 to 3023 777 to 1     Submitted on the opposite strand 777/778
(99 %)
7 diff
(99.2 %id)
TI_57175378   .a 2247 to 3023 806 to 30     Submitted on the opposite strand 777/807
(96 %)
0 diff
(100 %id)
BM477700 leiomyosarcoma, uterus .a 2317 to 2999 717 to 29     Submitted on the opposite strand 689/1154
(59 %)
0 diff
(100 %id)
BM459229 lymph, lymphoma, cell line .a 2407 to 3016 614 to 1     Submitted on the opposite strand 614/1152
(53 %)
9 diff
(99.3 %id)
AW050731 colon, colonic mucosa from 3 patients with Crohn'sdisease .a 2692 to 2955 266 to 5       262/266
(98 %)
0 diff
(100 %id)
CN372772 embryonic stem cells, cell lines H1, H7, andH9 .a 2722 to 3427 707 to 3     Submitted on the opposite strand 705/707
(99 %)
0 diff
(100 %id)
BM194410 leukopheresis .a 2730 to 2991 262 to 1       262/262
(100 %)
11 diff
(95.9 %id)
GD158950   .a 2787 to 2955 1 to 169   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 169/177
(95 %)
4 diff
(97.8 %id)
GD144499   .a 2788 to 2955 1 to 168   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 168/176
(95 %)
2 diff
(98.9 %id)
GD159691   .a 2788 to 2955 1 to 168   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 168/176
(95 %)
10 diff
(94.4 %id)
BE243638 leukopheresis .a 2827 to 2952 126 to 1       126/126
(100 %)
4 diff
(96.9 %id)
AW631239 2 pooled high-grade transitional celltumors, genitourinary tract .a 2840 to 2947 1 to 108       108/108
(100 %)
0 diff
(100 %id)
AI318215 bone marrow, stem cell 34+/38+ .a 2848 to 2953 1 to 106     Submitted on the opposite strand 106/106
(100 %)
7 diff
(93.4 %id)
C01301   .a 2888 to 2953 1 to 66       66/66
(100 %)
0 diff
(100 %id)
DB451516 testis .a 2982 to 3430 449 to 1     Submitted on the opposite strand 449/449
(100 %)
4 diff
(99.2 %id)
DB452121 testis .a 2992 to 3481 490 to 1     Submitted on the opposite strand 490/490
(100 %)
0 diff
(100 %id)
DB446023 testis .a 3091 to 3550 1 to 460       460/460
(100 %)
2 diff
(99.6 %id)
DB446772 testis .a 3093 to 3487 1 to 396       396/396
(100 %)
8 diff
(98.0 %id)
NM_133452.2   .a 3093 to 6678 1 to 3586   RefSeq, AAA   3586/3586
(100 %)
0 diff
(100 %id)
BI828565 brain, medulla .a 3112 to 3430 321 to 1     Submitted on the opposite strand 321/397
(80 %)
2 diff
(99.5 %id)
TI_57175261   .a 3112 to 3430 351 to 31     Submitted on the opposite strand 321/427
(75 %)
0 diff
(100 %id)
BQ929638 leiomyosarcoma, uterus .a 3185 to 3982 1 to 798       798/867
(92 %)
34 diff
(96.1 %id)
BG772457 testis .a 3198 to 3879 1 to 682       682/683
(99 %)
5 diff
(99.3 %id)
BI561260 testis .a 3199 to 3908 1 to 710       710/715
(99 %)
8 diff
(98.9 %id)
BE243835 leukopheresis .a 3201 to 3607 1 to 407       407/407
(100 %)
3 diff
(99.3 %id)
BE247377 leukopheresis .a 3201 to 3638 1 to 439       439/439
(100 %)
7 diff
(98.5 %id)
BM146217 leukopheresis .a 3202 to 3543 1 to 343       343/343
(100 %)
5 diff
(98.6 %id)
TI_44350904   .a 3203 to 3908 130 to 835       706/840
(84 %)
11 diff
(98.7 %id)
BM925227 pooled lung and spleen .a 3206 to 3982 2 to 777       776/1068
(72 %)
12 diff
(98.9 %id)
BC128436 PCR rescued clones .a 3207 to 3678 473 to 2     Submitted on the opposite strand 472/482
(97 %)
3 diff
(99.4 %id)
BX401103   .a 3208 to 4199 14 to 1003       990/1003
(98 %)
6 diff
(99.5 %id)
BU554022 ovary, teratocarcinoma, cell line .a 3209 to 3898 69 to 769       701/1053
(66 %)
21 diff
(98.1 %id)
CN372783 embryonic stem cells, cell lines H1, H7, andH9 .a 3210 to 3874 10 to 674       665/674
(98 %)
2 diff
(99.8 %id)
AL541355 placenta .a 3210 to 3967 13 to 767       755/776
(97 %)
12 diff
(98.5 %id)
CN372782 embryonic stem cells, cell lines H1, H7, andH9 .a 3211 to 3905 1 to 695       695/695
(100 %)
1 diff
(99.9 %id)
CN372777 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3212 to 3949 1 to 738       738/738
(100 %)
0 diff
(100 %id)
BM468002 leiomyosarcoma, uterus .a 3212 to 4168 30 to 997   available from MGC,   968/1165
(83 %)
39 diff
(96.7 %id)
BM545122 ovary (pool of 3) .a 3212 to 3982 20 to 790       771/1147
(67 %)
9 diff
(99.3 %id)
CD300022 testis .a 3212 to 3859 1 to 653       653/817
(79 %)
7 diff
(99.2 %id)
CN372784 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3214 to 3712 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BM926198 brain .a 3214 to 4055 1 to 847   tiling clone,   847/1031
(82 %)
11 diff
(99.0 %id)
AL524475 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 3215 to 4293 20 to 1087       1068/1087
(98 %)
22 diff
(98.0 %id)
BF310750 brain, neuroblastoma .a 3217 to 3877 1 to 650       650/877
(74 %)
25 diff
(97.2 %id)
BG751625 eye, normal pigmented retinal epithelium .a 3217 to 3884 1 to 668       668/669
(99 %)
2 diff
(99.8 %id)
BF305885 muscle, rhabdomyosarcoma .a 3218 to 3966 1 to 741       741/948
(78 %)
28 diff
(97.1 %id)
BG825735 muscle, rhabdomyosarcoma .a 3218 to 3908 1 to 692       692/692
(100 %)
5 diff
(99.3 %id)
BX375178 Neuroblastoma Cot 25-normalized .a 3219 to 3809 20 to 609       590/609
(96 %)
7 diff
(98.9 %id)
BF984117 duodenal adenocarcinoma, cell line, small intestine .a 3219 to 3897 1 to 668       668/900
(74 %)
16 diff
(98.3 %id)
BG257988 embryonal carcinoma, cell line, testis .a 3219 to 3853 1 to 635       635/635
(100 %)
0 diff
(100 %id)
CN372775 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3220 to 3972 12 to 764       753/764
(98 %)
6 diff
(99.3 %id)
BF346256 anaplastic oligodendroglioma with 1p/19qloss, brain .a 3222 to 3951 1 to 724       724/758
(95 %)
11 diff
(98.6 %id)
BM472361 melanotic melanoma, skin .a 3223 to 3896 92 to 782       691/1136
(60 %)
29 diff
(97.5 %id)
CN372781 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3224 to 3852 1 to 628       628/628
(100 %)
3 diff
(99.6 %id)
EL734302 mixed .a 3224 to 3908 1 to 684       684/685
(99 %)
7 diff
(99.0 %id)
TI_1948210213   .a 3224 to 3753 130 to 666       537/1445
(37 %)
30 diff
(98.0 %id)
BI333296 cervical carcinoma cell line, cervix .a 3225 to 3902 1 to 678       678/678
(100 %)
0 diff
(100 %id)
AL522840 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 3230 to 3513 1 to 282       282/286
(98 %)
4 diff
(98.7 %id)
CN372774 embryonic stem cells, cell lines H1, H7, andH9 .a 3231 to 3430 1 to 200       200/200
(100 %)
5 diff
(97.5 %id)
BE885742 leiomyosarcoma, uterus .a 3232 to 3937 1 to 702       702/703
(99 %)
10 diff
(98.6 %id)
BQ437075 embryonal carcinoma, cell line, testis .a 3234 to 3773 1 to 541       541/556
(97 %)
6 diff
(99.0 %id)
BE298434 muscle, rhabdomyosarcoma .a 3237 to 3774 1 to 538       538/538
(100 %)
0 diff
(100 %id)
BG032400 breast, mammary adenocarcinoma, cell line .a 3239 to 3922 1 to 683       683/683
(100 %)
4 diff
(99.5 %id)
TI_154164022   .a 3251 to 4132 79 to 950       872/925
(94 %)
21 diff
(97.8 %id)
BM543235 embryonal carcinoma, cell line, testis .a 3311 to 3985 1 to 683       683/1180
(57 %)
32 diff
(97.3 %id)
BI256263 cervical carcinoma cell line, cervix .a 3329 to 4268 1 to 941       865/942
(91 %)
42 diff
(95.6 %id)
BX343385 Neuroblastoma Cot 25-normalized .a 3365 to 4358 1 to 986       988/1012
(97 %)
19 diff
(98.2 %id)
BX353652 Neuroblastoma Cot 25-normalized .a 3365 to 4368 1 to 991       993/1017
(97 %)
13 diff
(98.8 %id)
BI335547 cervical carcinoma cell line, cervix .a 3395 to 3800 28 to 448       421/449
(93 %)
20 diff
(95.6 %id)
BE299234 muscle, rhabdomyosarcoma .a 3397 to 3841 1 to 443       443/447
(99 %)
11 diff
(97.6 %id)
CN372779 embryonic stem cells, cell lines H1, H7, andH9 .a 3419 to 4111 1 to 694       694/694
(100 %)
4 diff
(99.5 %id)
CA395513 eye, RPE/choroid .a 3457 to 4025 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BE895245 melanotic melanoma, skin .a 3472 to 4172 1 to 690       690/932
(74 %)
23 diff
(97.6 %id)
CO245501 Chondrosarcoma Lung Metastasis cell lines, lung .a 3485 to 4058 41 to 612       572/847
(67 %)
11 diff
(98.8 %id)
BQ420523 embryonal carcinoma, cell line, testis .a 3490 to 4302 18 to 829       812/1095
(74 %)
16 diff
(98.6 %id)
BU508490 leiomyosarcoma, uterus .a 3672 to 4487 1 to 819       819/895
(91 %)
13 diff
(98.6 %id)
BG032369 breast, mammary adenocarcinoma, cell line .a 3724 to 4481 1 to 751       751/751
(100 %)
20 diff
(97.4 %id)
BC037565 Cervix, carcinoma .a 3766 to 6678 11 to 2923   tiling clone, available from MGC, AAA   2913/2913
(100 %)
1 diff
(100.0 %id)
BI255037 cervical carcinoma cell line, cervix .a 3767 to 4594 1 to 825   available from MGC,   825/825
(100 %)
15 diff
(98.2 %id)
BF970177 adrenal cortex carcinoma, cell line, adrenal gland .a 3843 to 4566 1 to 721       721/726
(99 %)
11 diff
(98.5 %id)
BG476369 melanotic melanoma, skin .a 3844 to 4718 1 to 869       869/871
(99 %)
34 diff
(96.1 %id)
BE385357 melanotic melanoma, skin .a 3864 to 4355 1 to 492       492/492
(100 %)
1 diff
(99.8 %id)
BM459973 leiomyosarcoma, uterus .a 3866 to 4538 1 to 684       681/1192
(57 %)
29 diff
(97.6 %id)
BG911480 anaplastic oligodendroglioma with 1p/19qloss, brain .a 3932 to 4621 1 to 708       708/709
(99 %)
36 diff
(95.0 %id)
BM927616 lymph, lymphoma, cell line .a 4006 to 4678 22 to 696       675/1168
(57 %)
17 diff
(98.6 %id)
BG106652 lymph, lymphoma, cell line .a 4007 to 4595 1 to 583       583/584
(99 %)
7 diff
(98.9 %id)
BM909539 lymph, lymphoma, cell line .a 4007 to 4483 1 to 477       477/1320
(36 %)
2 diff
(99.9 %id)
BE313942 brain, neuroblastoma .a 4055 to 4665 1 to 610       610/610
(100 %)
14 diff
(97.8 %id)
BX282435 leiomyosarcoma, uterus .a 4182 to 4673 1 to 492       492/492
(100 %)
0 diff
(100 %id)
BM460975 leiomyosarcoma, uterus .a 4183 to 4916 1 to 746       746/1019
(73 %)
14 diff
(98.7 %id)
BQ062399 lymph, lymphoma, cell line .a 4191 to 4863 32 to 712       681/1206
(56 %)
23 diff
(98.1 %id)
BE885049 leiomyosarcoma, uterus .a 4319 to 4551 1 to 232       232/232
(100 %)
1 diff
(99.6 %id)
BF127585 leiomyosarcoma cell line, uterus .a 4322 to 4831 1 to 501       501/553
(90 %)
14 diff
(97.5 %id)
BG752149 eye, normal pigmented retinal epithelium .a 4332 to 4950 1 to 628       628/630
(99 %)
28 diff
(95.6 %id)
BU856370 ovary, teratocarcinoma, cell line .a 4427 to 5213 1 to 793       793/942
(84 %)
18 diff
(98.1 %id)
BU930900 ovary, teratocarcinoma, cell line .a 4427 to 5189 1 to 767       767/947
(80 %)
27 diff
(97.2 %id)
BQ058584 lymph, lymphoma, cell line .a 4435 to 5213 1 to 788       788/1048
(75 %)
17 diff
(98.4 %id)
BQ062308 lymph, lymphoma, cell line .a 4435 to 5285 1 to 860       860/1043
(82 %)
16 diff
(98.5 %id)
BE892242 melanotic melanoma, skin .a 4500 to 4551 1 to 51       51/51
(100 %)
1 diff
(98.1 %id)
BU168527 melanotic melanoma, cell line, skin .a 4582 to 5206 1 to 622       622/894
(69 %)
23 diff
(97.5 %id)
BQ233371 leiomyosarcoma, uterus .a 4585 to 5500 1 to 921       921/1026
(89 %)
18 diff
(98.3 %id)
BE257555 eye, retinoblastoma .a 4623 to 5068 1 to 455       455/529
(86 %)
22 diff
(95.9 %id)
BQ212403 embryonal carcinoma, cell line, testis .a 4772 to 5614 1 to 863       863/863
(100 %)
24 diff
(97.3 %id)
CR746909 large cell carcinoma, lung .a 4799 to 5304 11 to 516       506/516
(98 %)
6 diff
(98.9 %id)
BQ430683 large cell carcinoma, lung .a 4801 to 5555 1 to 767   tiling clone,   767/1228
(62 %)
18 diff
(98.6 %id)
BG393620 embryonal carcinoma, cell line, testis .a 4821 to 5386 1 to 558       558/558
(100 %)
11 diff
(98.1 %id)
BI917016 brain .a 4855 to 5504 1 to 671       671/722
(92 %)
38 diff
(94.8 %id)
BG119435 adenocarcinoma, cell line, Liver .a 4860 to 5504 23 to 668       655/669
(97 %)
70 diff
(89.6 %id)
TI_57239424   .a 4860 to 5504 22 to 699       690/750
(92 %)
93 diff
(87.6 %id)
AL134122 brain .a 4883 to 5175 31 to 323       294/323
(91 %)
7 diff
(97.9 %id)
CN371406 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4895 to 5499 13 to 616       604/616
(98 %)
6 diff
(99.1 %id)
DR759660 embryonic stem .a 4905 to 5653 1 to 749       749/749
(100 %)
5 diff
(99.4 %id)
CN371407 embryonic stem cells, DMSO-treated H9 cellline .a 4910 to 5441 1 to 532       532/532
(100 %)
0 diff
(100 %id)
CD558284 White Matter .a 4941 to 5555 18 to 640       623/1014
(61 %)
22 diff
(97.9 %id)
BG680389 skin, squamous cell carcinoma .a 4965 to 5690 1 to 729       729/729
(100 %)
9 diff
(98.8 %id)
BM551727 astrocytoma grade IV, cell line, brain .a 4967 to 5946 1 to 993       993/1043
(95 %)
30 diff
(97.2 %id)
BG330328 large cell carcinoma, lung .a 4996 to 5739 1 to 741       741/749
(98 %)
21 diff
(97.2 %id)
TI_57244659   .a 5027 to 5711 66 to 747       682/748
(91 %)
12 diff
(98.4 %id)
BG750229 eye, normal pigmented retinal epithelium .a 5033 to 5691 1 to 658       658/658
(100 %)
4 diff
(99.4 %id)
BI917369 brain .a 5034 to 5711 1 to 676       676/677
(99 %)
7 diff
(99.0 %id)
BM561555 blood, natural killer cells, cell line .a 5035 to 5913 1 to 912       880/1009
(87 %)
37 diff
(96.4 %id)
BQ926069 sciatic nerve .a 5049 to 5819 1 to 780       780/938
(83 %)
19 diff
(98.0 %id)
CR590285 B cells (Ramos cell line) Cot 25-normalized .a 5067 to 6648 1 to 1582       1582/1582
(100 %)
0 diff
(100 %id)
BX385159   .a 5067 to 5893 1 to 827   fully sequenced,   827/827
(100 %)
1 diff
(99.9 %id)
BE871955 adenocarcinoma, colon .a 5067 to 5651 29 to 615       590/615
(95 %)
30 diff
(95.2 %id)
BE793354 lung, small cell carcinoma .a 5084 to 5799 1 to 716       716/764
(93 %)
15 diff
(98.1 %id)
BG678653 skin, squamous cell carcinoma .a 5085 to 5774 1 to 674       674/675
(99 %)
10 diff
(98.6 %id)
EC567957 Prostate .a 5130 to 5213 1 to 81       81/90
(90 %)
5 diff
(94.5 %id)
BU857727 adenocarcinoma, cell line, breast .a 5132 to 6013 1 to 888       888/935
(94 %)
17 diff
(98.2 %id)
BU944803 adenocarcinoma, cell line, breast .a 5132 to 5960 1 to 835       835/848
(98 %)
9 diff
(99.0 %id)
BE547641 cervical carcinoma cell line, cervix .a 5137 to 5908 1 to 784       730/804
(90 %)
57 diff
(93.0 %id)
AW581609 pnet .a 5142 to 5332 202 to 3       200/236
(84 %)
16 diff
(93.3 %id)
BU177446 melanotic melanoma, skin .a 5154 to 5984 28 to 873       846/888
(95 %)
37 diff
(95.9 %id)
BG120302 adenocarcinoma, cell line, Liver .a 5161 to 5762 1 to 583       583/892
(65 %)
27 diff
(97.0 %id)
AI298330 placenta .a 5180 to 5549 370 to 1       370/370
(100 %)
0 diff
(100 %id)
BM013407 brain, neuroblastoma, cell line .a 5181 to 6024 1 to 840       840/879
(95 %)
35 diff
(96.1 %id)
TI_59380226   .a 5182 to 6024 93 to 931       839/878
(95 %)
34 diff
(96.2 %id)
BG420299 Kidney, renal cell adenocarcinoma .a 5193 to 6023 1 to 826       826/908
(90 %)
28 diff
(97.0 %id)
BI226204 Burkitt lymphoma, lymph .a 5212 to 5838 1 to 636       636/1042
(61 %)
15 diff
(98.6 %id)
BQ708677 Spleen .a 5215 to 5966 18 to 774       757/976
(77 %)
22 diff
(97.8 %id)
BX480258   .a 5217 to 5786 1 to 570       570/570
(100 %)
3 diff
(99.5 %id)
BF795466 lymph, lymphoma, cell line .a 5217 to 5982 1 to 755       755/1063
(71 %)
20 diff
(98.2 %id)
BF793261 adrenal cortex carcinoma, cell line, adrenal gland .a 5218 to 5964 1 to 756       756/867
(87 %)
33 diff
(96.2 %id)
CR998144 T-Lymphocytes .a 5219 to 5939 1 to 722       722/724
(99 %)
2 diff
(99.8 %id)
BQ054274 blood, natural killer cells, cell line .a 5223 to 6055 1 to 851       851/1089
(78 %)
29 diff
(97.4 %id)
BE513294 Burkitt lymphoma, lymph .a 5232 to 5866 1 to 633       633/633
(100 %)
4 diff
(99.4 %id)
BG748733 eye, normal pigmented retinal epithelium .a 5280 to 6174 1 to 879       879/917
(95 %)
19 diff
(98.0 %id)
BG115821 duodenal adenocarcinoma, cell line, small intestine .a 5322 to 5835 1 to 522       522/1169
(44 %)
9 diff
(99.3 %id)
AA322816 brain, cerebellum .a 5360 to 5624 1 to 265       265/265
(100 %)
1 diff
(99.7 %id)
BI117137 lung, small cell carcinoma .a 5395 to 5839 1 to 444       444/976
(45 %)
5 diff
(99.5 %id)
AA311942   .a 5478 to 5836 1 to 360       360/360
(100 %)
3 diff
(99.2 %id)
BM712998 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 5509 to 5881 12 to 384   fully sequenced, AAA   373/384
(97 %)
6 diff
(98.5 %id)
BM714091 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 5509 to 5881 12 to 384   fully sequenced, AAA   373/384
(97 %)
6 diff
(98.5 %id)
BM676185 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 5548 to 5881 345 to 12   fully sequenced, AAA   334/334
(100 %)
0 diff
(100 %id)
BM675275 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 5548 to 5881 345 to 12   fully sequenced, AAA   334/334
(100 %)
0 diff
(100 %id)
AL524474 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 5648 to 6627 969 to 1       969/1094
(88 %)
45 diff
(95.9 %id)
AL568864 placenta .a 5709 to 6603 893 to 1       893/901
(99 %)
35 diff
(96.2 %id)
AL562135 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 5803 to 6641 838 to 1       838/838
(100 %)
2 diff
(99.8 %id)
BX385158   .a 5863 to 6628 796 to 22   fully sequenced,   775/796
(97 %)
14 diff
(98.3 %id)
BX374149   .a 6255 to 6647 425 to 26       400/541
(73 %)
0 diff
(100 %id)
CR982084 T-Lymphocytes .b 1 to 583 1 to 583   tiling clone,   583/585
(99 %)
1 diff
(99.9 %id)
DC425414   .b 12 to 560 1 to 549       549/549
(100 %)
0 diff
(100 %id)
CR999669 T-Lymphocytes .b 162 to 907 1 to 747       747/751
(99 %)
2 diff
(99.8 %id)
AK312826 thymus .b 166 to 1864 1 to 1699 L178P     1699/1699
(100 %)
3 diff
(99.9 %id)
NM_002162.3   .b 166 to 1943 1 to 1778 exact RefSeq, AAA   1778/1778
(100 %)
0 diff
(100 %id)
BM194243 leukopheresis .b 166 to 637 1 to 472       472/473
(99 %)
12 diff
(97.5 %id)
DC405801 thymus .b 166 to 732 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
AK226023 Spleen .b 167 to 1942 1 to 1776 exact AAA   1776/1776
(100 %)
1 diff
(100.0 %id)
DC345052 colon .b 167 to 728 1 to 562       562/562
(100 %)
4 diff
(99.3 %id)
BP340214 Spleen .b 167 to 747 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DC390289 Spleen .b 167 to 718 1 to 552       552/552
(100 %)
3 diff
(99.5 %id)
DC404958 thymus .b 167 to 712 1 to 546       546/546
(100 %)
0 diff
(100 %id)
DC405133 thymus .b 167 to 716 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
DC405208 thymus .b 167 to 732 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
DC406140 thymus .b 167 to 694 1 to 528       528/528
(100 %)
0 diff
(100 %id)
DC407188 thymus .b 167 to 728 1 to 562       562/562
(100 %)
2 diff
(99.7 %id)
AU122157 mammary gland .b 168 to 985 2 to 810   capped   809/820
(98 %)
17 diff
(98.0 %id)
BM147249 leukopheresis .b 178 to 676 1 to 499       499/499
(100 %)
6 diff
(98.8 %id)
BM194205 leukopheresis .b 178 to 687 1 to 510       510/511
(99 %)
6 diff
(98.9 %id)
BE242237 leukopheresis .b 178 to 382 1 to 205       205/205
(100 %)
2 diff
(99.1 %id)
DC339812 thalamus .b 179 to 557 1 to 379       379/379
(100 %)
1 diff
(99.8 %id)
DC391647 Spleen .b 179 to 662 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
DC392521 stomach .b 179 to 732 1 to 554       554/554
(100 %)
4 diff
(99.3 %id)
DC295427 synovial membrane tissue from rheumatioidarthritis .b 179 to 758 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BX422085 T cells (Jurkat cell line) .b 184 to 861 1 to 678       678/678
(100 %)
2 diff
(99.8 %id)
CR987266 T-Lymphocytes .b 184 to 915 1 to 732       732/734
(99 %)
1 diff
(99.9 %id)
BX443599 T cells (Jurkat cell line) .b 185 to 1078 1 to 874       874/924
(94 %)
28 diff
(97.0 %id)
CR594982 Placenta Cot 25-normalized .b 186 to 1916 1 to 1731 exact     1731/1731
(100 %)
0 diff
(100 %id)
BX359439 Placenta Cot 25-normalized .b 186 to 1046 1 to 853   fully sequenced,   853/853
(100 %)
4 diff
(99.6 %id)
AL709279 human skeletal muscle .b 187 to 787 1 to 601       601/601
(100 %)
4 diff
(99.4 %id)
CR992584 T-Lymphocytes .b 187 to 913 1 to 727       727/729
(99 %)
1 diff
(99.9 %id)
DC387982 small intestine .b 192 to 745 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
DC405948 thymus .b 192 to 743 1 to 552       552/552
(100 %)
2 diff
(99.7 %id)
CR979825 T-Lymphocytes .b 196 to 1062 1 to 867       867/867
(100 %)
3 diff
(99.7 %id)
AL531288 brain, fetal liver, Liver, neuroblastoma cells .b 198 to 1082 1 to 877       877/924
(94 %)
16 diff
(98.3 %id)
CR983457 T-Lymphocytes .b 202 to 898 1 to 697       697/698
(99 %)
1 diff
(99.9 %id)
X69711   .b 206 to 1942 1 to 1737 R115G D143G AAA   1737/1737
(100 %)
7 diff
(99.6 %id)
BX411393 fetal liver, Liver .b 209 to 1125 913 to 1       913/913
(100 %)
5 diff
(99.5 %id)
DA581228 lung .b 209 to 686 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
DA940924 Spleen .b 210 to 792 2 to 585   capped   584/584
(100 %)
3 diff
(99.5 %id)
DA960003 Spleen .b 210 to 756 2 to 548   capped   547/547
(100 %)
4 diff
(99.3 %id)
DA972765 synovial membrane tissue from rheumatioidarthritis .b 210 to 665 2 to 457   capped   456/456
(100 %)
2 diff
(99.6 %id)
BM193209 leukopheresis .b 210 to 378 1 to 169       169/180
(93 %)
5 diff
(97.3 %id)
DB124742 thymus .b 210 to 761 2 to 553   capped   552/552
(100 %)
4 diff
(99.3 %id)
BM795679 stomach .b 211 to 663 1 to 453       453/453
(100 %)
1 diff
(99.8 %id)
DA372328 thalamus .b 212 to 770 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
DA433145 cord Blood .b 212 to 760 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA433338 cord Blood .b 212 to 765 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA620526   .b 212 to 779 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA673657   .b 212 to 798 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA676513   .b 212 to 781 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA817488   .b 212 to 785 2 to 575   capped   574/574
(100 %)
4 diff
(99.4 %id)
DA916042 small intestine .b 212 to 674 2 to 464   capped   463/463
(100 %)
3 diff
(99.4 %id)
DA919352 small intestine .b 212 to 779 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
DA933279 Spleen .b 212 to 775 2 to 565   capped   564/565
(99 %)
1 diff
(99.9 %id)
DA934149 Spleen .b 212 to 801 2 to 591   capped   590/590
(100 %)
3 diff
(99.5 %id)
DA946972 Spleen .b 212 to 787 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DA948873 Spleen .b 212 to 773 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA950114 Spleen .b 212 to 757 2 to 547   capped   546/546
(100 %)
2 diff
(99.7 %id)
DA954184 Spleen .b 212 to 790 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DA976558 synovial membrane tissue from rheumatioidarthritis .b 212 to 773 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DB011318 colon, tumor tissue .b 212 to 796 2 to 586   capped   585/585
(100 %)
3 diff
(99.5 %id)
DB106589 thymus .b 212 to 767 2 to 557   capped   556/556
(100 %)
4 diff
(99.3 %id)
DB110201 thymus .b 212 to 785 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
X69819 tonsil .b 213 to 1943 1 to 1731 R115G D143G AAA   1731/1731
(100 %)
3 diff
(99.9 %id)
BI768825 pooled lung and spleen .b 214 to 849 1 to 634       634/683
(92 %)
10 diff
(98.6 %id)
DA672261   .b 214 to 786 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
BC058903 Lung, Spleen, fetal, pooled .b 215 to 1943 1 to 1729 exact available from MGC, AAA   1729/1729
(100 %)
1 diff
(100.0 %id)
TI_57181487   .b 215 to 849 35 to 667       633/716
(88 %)
16 diff
(97.8 %id)
DA675151   .b 215 to 798 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA670269   .b 216 to 766 2 to 552   capped   551/553
(99 %)
1 diff
(99.9 %id)
DA671136   .b 216 to 808 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DA672007   .b 216 to 807 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA672035   .b 216 to 806 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DA672340   .b 216 to 799 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA672560   .b 216 to 814 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
DA672671   .b 216 to 813 2 to 599   capped   598/598
(100 %)
2 diff
(99.7 %id)
DA674042   .b 216 to 800 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA675256   .b 216 to 801 2 to 587   capped   586/586
(100 %)
2 diff
(99.7 %id)
DA934454 Spleen .b 216 to 799 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DA675390   .b 217 to 813 2 to 598   capped   597/597
(100 %)
1 diff
(99.9 %id)
DA673002   .b 219 to 814 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DA674335   .b 219 to 817 2 to 600   capped   599/599
(100 %)
2 diff
(99.7 %id)
DA958124 Spleen .b 219 to 754 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
BI819679 pooled brain, lung, testis .b 220 to 847 1 to 628   available from MGC,   628/628
(100 %)
5 diff
(99.3 %id)
TI_57200227   .b 220 to 847 66 to 693       628/693
(90 %)
9 diff
(98.8 %id)
TI_57167919   .b 220 to 863 26 to 668       643/707
(90 %)
18 diff
(97.5 %id)
S50015   .b 220 to 1941 1 to 1722 S60F R115G D143G AAA   1722/1722
(100 %)
7 diff
(99.6 %id)
CR623746 B cells (Ramos cell line) Cot 25-normalized .b 221 to 1931 1 to 1711 exact     1711/1711
(100 %)
0 diff
(100 %id)
BX367215   .b 221 to 959 1 to 739   fully sequenced,   739/739
(100 %)
4 diff
(99.5 %id)
BX342940   .b 221 to 1099 1 to 901       901/939
(95 %)
42 diff
(95.6 %id)
BC040123 Brain, Lung, Testis, adult, pooled whole .b 221 to 1943 1 to 1723 exact tiling clone, available from MGC, AAA   1723/1723
(100 %)
2 diff
(99.9 %id)
BG341069 B-cells, primary B-cells from tonsils (cell line) .b 222 to 845 1 to 618       618/640
(96 %)
11 diff
(98.3 %id)
BQ072687 leukocyte .b 225 to 1072 13 to 887       875/1088
(80 %)
38 diff
(96.6 %id)
BI832447 pooled pancreas and spleen .b 226 to 1009 1 to 781       783/781
(100 %)
30 diff
(96.2 %id)
BI837069 pooled pancreas and spleen .b 226 to 863 1 to 637       637/676
(94 %)
14 diff
(98.0 %id)
TI_57162158   .b 226 to 1009 60 to 840       783/840
(93 %)
34 diff
(96.0 %id)
CR987063 T-Lymphocytes .b 226 to 978 1 to 754       754/755
(99 %)
2 diff
(99.8 %id)
CR982322 T-Lymphocytes .b 226 to 1119 1 to 898       898/900
(99 %)
10 diff
(98.9 %id)
CT001811 T-Lymphocytes .b 226 to 708 1 to 483       483/485
(99 %)
1 diff
(99.8 %id)
CR983330 T-Lymphocytes .b 227 to 1157 1 to 932       932/943
(98 %)
5 diff
(99.5 %id)
BM918698 pooled pancreas and spleen .b 228 to 1041 14 to 826       813/1109
(73 %)
23 diff
(98.0 %id)
BI837246 pooled pancreas and spleen .b 229 to 998 1 to 767       771/770
(100 %)
39 diff
(95.0 %id)
TI_57168324   .b 229 to 998 29 to 795       771/798
(96 %)
40 diff
(95.0 %id)
CR979444 T-Lymphocytes .b 233 to 829 1 to 597       597/599
(99 %)
2 diff
(99.7 %id)
CR590853 B cells (Ramos cell line) Cot 25-normalized .b 239 to 1898 1 to 1660       1660/1660
(100 %)
0 diff
(100 %id)
BX343234   .b 239 to 1101 1 to 862   fully sequenced,   862/862
(100 %)
2 diff
(99.8 %id)
BE270839 Burkitt lymphoma, lymph .b 241 to 842 1 to 597       597/604
(98 %)
7 diff
(98.9 %id)
CR974614 T-Lymphocytes .b 244 to 974 1 to 733       733/734
(99 %)
7 diff
(99.1 %id)
BI839162 pooled pancreas and spleen .b 245 to 871 28 to 659       632/854
(74 %)
30 diff
(96.5 %id)
TI_57165407   .b 245 to 871 28 to 659       632/854
(74 %)
30 diff
(96.5 %id)
AF340060 blood .b 248 to 1884 1 to 1637       1637/1641
(99 %)
4 diff
(99.8 %id)
AF340061 blood .b 248 to 1877 1 to 1630       1630/1630
(100 %)
3 diff
(99.9 %id)
TI_154188531   .b 255 to 869 120 to 731       612/888
(68 %)
9 diff
(99.0 %id)
BY995973   .b 261 to 895 9 to 643       635/643
(98 %)
7 diff
(99.0 %id)
CR983262 T-Lymphocytes .b 272 to 964 1 to 693       693/695
(99 %)
2 diff
(99.8 %id)
BI837057 pooled pancreas and spleen .b 299 to 1005 11 to 715       705/715
(98 %)
19 diff
(97.4 %id)
TI_57167907   .b 299 to 1005 42 to 746       705/746
(94 %)
19 diff
(97.5 %id)
BM147584 leukopheresis .b 504 to 964 1 to 461       461/461
(100 %)
5 diff
(99.0 %id)
BG686305 B-cells, primary B-cells from tonsils (cell line) .b 529 to 1235 1 to 707       707/708
(99 %)
12 diff
(98.4 %id)
BP382150 adipose tissue .b 695 to 1317 1 to 622       622/624
(99 %)
9 diff
(98.6 %id)
CN388247 embryonic stem cells, cell lines H1, H7, andH9 .b 706 to 1394 9 to 697       689/697
(98 %)
6 diff
(99.2 %id)
DT217971 brain .b 711 to 1408 1 to 698       698/698
(100 %)
0 diff
(100 %id)
BQ719653 sympathetic trunk .b 767 to 1637 1 to 882       882/921
(95 %)
15 diff
(98.4 %id)
BM144739 leukopheresis .b 826 to 1237 412 to 1       412/412
(100 %)
4 diff
(99.1 %id)
T28913 blood, white blood cells .b 854 to 1129 1 to 276       276/276
(100 %)
1 diff
(99.7 %id)
AL531287 brain, fetal liver, Liver, neuroblastoma cells .b 872 to 1898 1018 to 1       1018/1018
(100 %)
34 diff
(96.7 %id)
BF882694 lung_tumor .b 901 to 1426 1 to 526       526/526
(100 %)
1 diff
(99.9 %id)
BG180058 adenocarcinoma, cell line, Prostate .b 913 to 1657 1 to 751       751/877
(85 %)
23 diff
(97.4 %id)
BX367214   .b 929 to 1931 996 to 1   fully sequenced,   996/996
(100 %)
23 diff
(97.7 %id)
BX359438 Placenta Cot 25-normalized .b 1016 to 1904 894 to 10   fully sequenced,   885/894
(98 %)
5 diff
(99.5 %id)
BX343233   .b 1071 to 1889 819 to 10   fully sequenced,   810/819
(98 %)
0 diff
(100 %id)
CR983338 T-Lymphocytes .b 1102 to 1864 1 to 764       764/764
(100 %)
1 diff
(99.9 %id)
CB107057 Liver .b 1151 to 1603 1 to 453       453/453
(100 %)
2 diff
(99.6 %id)
W00853 melanocyte .b 1161 to 1514 9 to 361       353/411
(85 %)
20 diff
(95.2 %id)
CN388246 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1194 to 1619 1 to 426       426/426
(100 %)
1 diff
(99.8 %id)
BE271024 Burkitt lymphoma, lymph .b 1379 to 1881 537 to 27       511/611
(83 %)
8 diff
(98.7 %id)
AU147815 mammary gland .b 1415 to 1943 530 to 1       530/560
(94 %)
12 diff
(97.9 %id)
AK309643   .c 1 to 2021 4 to 2024 exact tiling clone,   2024/2024
(100 %)
0 diff
(100 %id)
DC429328   .c 1 to 570 4 to 573       573/573
(100 %)
0 diff
(100 %id)
DC429272   .d 1 to 584 1 to 584   tiling clone,   584/584
(100 %)
0 diff
(100 %id)
BX443517 T cells (Jurkat cell line) .d 494 to 1115 377 to 991   tiling clone,   619/1039
(59 %)
104 diff
(90.0 %id)
AI383988 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 863 to 1519 650 to 1   tiling clone,   650/650
(100 %)
13 diff
(98.0 %id)
AL524608 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 1 to 1032 1 to 1029   AAA   1029/1074
(95 %)
10 diff
(99.1 %id)
BX395348 Neuroblastoma Cot 50-normalized .e 1 to 340 1 to 340   tiling clone,   340/340
(100 %)
0 diff
(100 %id)
CR985342 T-Lymphocytes .e 32 to 568 1 to 537       537/538
(99 %)
2 diff
(99.7 %id)
AA309904   .e 63 to 472 1 to 410       410/410
(100 %)
2 diff
(99.6 %id)
DB005183 breast, tumor tissue .e 65 to 627 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
BU502531 carcinoma, cell line, Prostate .e 80 to 762 1 to 683       683/707
(96 %)
4 diff
(99.5 %id)
BM786293 Ascites, stomach .e 83 to 681 1 to 599       599/599
(100 %)
1 diff
(99.9 %id)
CD557260 testis .e 84 to 973 1 to 894   tiling clone,   894/894
(100 %)
9 diff
(99.0 %id)
DA806538 brain .e 85 to 636 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DB253477 uterus .e 85 to 645 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
TI_57201166   .e 87 to 768 39 to 731       703/878
(80 %)
60 diff
(93.2 %id)
AA701550 liver and spleen .e 89 to 559 1 to 469     Submitted on the opposite strand 469/469
(100 %)
5 diff
(99.0 %id)
BM823886 Ascites, stomach .e 105 to 597 1 to 493       493/493
(100 %)
1 diff
(99.8 %id)
FN105786 breast carcinoma .e 121 to 201 1 to 81       81/81
(100 %)
0 diff
(100 %id)
AA157413   .e 148 to 440 2 to 298   fully sequenced,   297/298
(99 %)
4 diff
(98.7 %id)
AI453531 pooled .e 148 to 770 628 to 6       623/639
(97 %)
1 diff
(99.9 %id)
BE222719 brain, oligodendroglioma .e 185 to 770 588 to 3       586/588
(99 %)
0 diff
(100 %id)
CT004916 T-Lymphocytes .e 189 to 764 1 to 576       576/576
(100 %)
0 diff
(100 %id)
AA341290 Kidney .e 209 to 490 1 to 282       282/282
(100 %)
0 diff
(100 %id)
AA456903 germinal center B cell .e 262 to 445 1 to 184       184/184
(100 %)
12 diff
(93.5 %id)
AA848098 germinal center B cell .e 263 to 726 461 to 1       461/461
(100 %)
18 diff
(96.1 %id)
CV030094 mixed .e 353 to 498 1 to 146       146/248
(58 %)
1 diff
(99.6 %id)
BG987452 head_neck .e 358 to 526 1 to 166       166/166
(100 %)
8 diff
(95.2 %id)
AA157298   .e 410 to 769 360 to 1   fully sequenced,   360/360
(100 %)
7 diff
(98.1 %id)
AW964828   .e 497 to 1086 590 to 1     Submitted on the opposite strand 590/591
(99 %)
10 diff
(98.4 %id)
AI739355 colon, colon tumor, RER+ .e 508 to 938 432 to 1       432/432
(100 %)
1 diff
(99.8 %id)
AA829770 germinal center B cell .e 590 to 1097 505 to 1   tiling clone,   505/505
(100 %)
3 diff
(99.5 %id)
BM310518 Pancreas, Purified pancreatic islet .e 643 to 1086 444 to 1       444/444
(100 %)
0 diff
(100 %id)
GD145118   .e 650 to 769 1 to 121       121/137
(88 %)
7 diff
(94.9 %id)
GD145174   .e 650 to 769 1 to 120       120/136
(88 %)
5 diff
(96.4 %id)
BQ636667 eye, retina .e 1022 to 1614 1 to 595   tiling clone,   595/595
(100 %)
1 diff
(99.9 %id)
BF345248 anaplastic oligodendroglioma with 1p/19qloss, brain .e 1201 to 1891 1 to 679       679/842
(80 %)
22 diff
(97.4 %id)
AL524607 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 1405 to 2296 977 to 93   tiling clone,   885/1024
(86 %)
18 diff
(98.3 %id)
CR990792 T-Lymphocytes .e 1479 to 2218 1 to 741       741/742
(99 %)
2 diff
(99.8 %id)
BM756490 Ascites, stomach .e 1510 to 1807 20 to 317       298/317
(94 %)
6 diff
(98.2 %id)
BM770116 Ascites, stomach .e 1510 to 2105 20 to 613       594/616
(96 %)
13 diff
(97.9 %id)
BM770178 Ascites, stomach .e 1510 to 2142 20 to 652   tiling clone,   633/652
(97 %)
6 diff
(99.1 %id)
BM771193 Ascites, stomach .e 1510 to 2153 20 to 662       643/662
(97 %)
7 diff
(99.0 %id)
BM771447 Ascites, stomach .e 1510 to 2097 20 to 606       587/609
(96 %)
8 diff
(98.7 %id)
BM771939 Ascites, stomach .e 1510 to 2200 20 to 709       690/709
(97 %)
7 diff
(99.1 %id)
BM766818 Ascites, stomach .e 1510 to 1823 20 to 334       315/334
(94 %)
6 diff
(98.3 %id)
BM742279 stomach .e 1510 to 2056 20 to 565       546/565
(96 %)
7 diff
(98.8 %id)
BM765851 stomach .e 1510 to 2097 20 to 606       587/609
(96 %)
8 diff
(98.7 %id)
BM740216 Ascites, stomach .e 1521 to 2119 21 to 621       604/621
(97 %)
6 diff
(99.1 %id)
BM754951 Ascites, stomach .e 1521 to 1952 28 to 458       434/458
(94 %)
8 diff
(98.3 %id)
DB453669 testis .f 1 to 501 1 to 502   tiling clone,   502/502
(100 %)
4 diff
(99.3 %id)
CF272660   .f 396 to 2245 1 to 1844   tiling clone,   1844/1844
(100 %)
18 diff
(99.1 %id)
AB075858 brain .g 1 to 4693 1 to 4694 exact tiling clone, available from KIAA,   4694/4694
(100 %)
2 diff
(100.0 %id)
CN372778 embryonic stem cells, cell lines H1, H7, andH9 .g 9 to 690 1 to 681       681/681
(100 %)
1 diff
(99.9 %id)
CX866126 embryonic stem .g 1307 to 2011 1 to 705       705/705
(100 %)
1 diff
(99.9 %id)
AW732650 Burkitt lymphoma, lymph .g 3225 to 3688 1 to 463       463/463
(100 %)
6 diff
(98.8 %id)
BU860222 adenocarcinoma, cell line, breast .g 3302 to 3950 1 to 658       658/847
(77 %)
15 diff
(98.3 %id)
BM019389 astrocytoma grade IV, cell line, brain .g 3305 to 4102 1 to 795       795/795
(100 %)
21 diff
(97.4 %id)
TI_59390070   .g 3306 to 4102 116 to 909       794/794
(100 %)
20 diff
(97.5 %id)
BQ709242 Spleen .g 3325 to 3944 1 to 634       634/1047
(60 %)
22 diff
(97.9 %id)
BQ648088 hepatocellular carcinoma, cell line, Liver .g 3336 to 4239 1 to 913       913/935
(97 %)
39 diff
(95.9 %id)
BQ651958 hepatocellular carcinoma, cell line, Liver .g 3337 to 3984 1 to 653       653/972
(67 %)
16 diff
(98.4 %id)
BU500784   .g 3383 to 4239 11 to 879       869/900
(96 %)
23 diff
(97.5 %id)
CX783807 human embryonic stem cells .g 3453 to 4220 1 to 768       768/768
(100 %)
0 diff
(100 %id)
CN372773 embryonic stem cells, cell lines H1, H7, andH9 .g 3458 to 4109 22 to 673       652/673
(96 %)
6 diff
(99.2 %id)
BE792878 lung, small cell carcinoma .g 3463 to 4259 1 to 777       777/958
(81 %)
25 diff
(97.4 %id)
BF343055 brain, glioblastoma with EGFR amplification .g 3497 to 4278 1 to 765       765/851
(89 %)
36 diff
(95.8 %id)
BM470531 leiomyosarcoma, uterus .g 3514 to 4076 16 to 579       564/1136
(49 %)
6 diff
(99.5 %id)
BM729222 eye, fetal eye .g 3527 to 4073 23 to 569       547/569
(96 %)
6 diff
(99.0 %id)
BI087603 cervix .g 3529 to 4264 1 to 752       752/752
(100 %)
30 diff
(96.1 %id)
BQ898280 epidermoid carcinoma, cell line, salivary gland .g 3549 to 4378 1 to 843       843/892
(94 %)
29 diff
(96.8 %id)
BQ671288 epidermoid carcinoma, cell line, salivary gland .g 3549 to 4149 1 to 603       603/999
(60 %)
10 diff
(99.0 %id)
BQ670354 epidermoid carcinoma, cell line, salivary gland .g 3549 to 4463 1 to 936       936/1001
(93 %)
49 diff
(95.2 %id)
AA479259 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 3560 to 3953 1 to 394       394/394
(100 %)
5 diff
(98.8 %id)
R18466 whole brain .g 3573 to 3952 1 to 386       386/388
(99 %)
16 diff
(95.9 %id)
BF724596 eye, Iris .g 3578 to 3987 1 to 410       410/410
(100 %)
0 diff
(100 %id)
BE391222 endometrium, adenocarcinoma cell line, uterus .g 3580 to 4293 1 to 707       707/713
(99 %)
20 diff
(97.2 %id)
BI085128 astrocytoma grade IV, cell line, brain .g 3612 to 4133 1 to 517   fully sequenced,   517/517
(100 %)
7 diff
(98.7 %id)
BE910368 epithelioid carcinoma, Pancreas .g 3613 to 4309 1 to 695       695/1024
(67 %)
21 diff
(98.0 %id)
BM010710 amelanotic melanoma, cell line, skin .g 3645 to 4427 1 to 782       782/783
(99 %)
16 diff
(98.0 %id)
TI_59385556   .g 3646 to 4427 60 to 840       781/782
(99 %)
16 diff
(98.0 %id)
BM916540 amelanotic melanoma, cell line, skin .g 3647 to 4303 1 to 668       668/1186
(56 %)
16 diff
(98.7 %id)
BX343384 Neuroblastoma Cot 25-normalized .g 3655 to 4661 1009 to 1       1009/1089
(92 %)
35 diff
(96.8 %id)
BQ709668 Spleen .g 3656 to 4582 1 to 948       948/950
(99 %)
44 diff
(95.4 %id)
BG118441 adenocarcinoma, cell line, Liver .g 3689 to 4450 1 to 754       754/945
(79 %)
24 diff
(97.5 %id)
BE251146 eye, retinoblastoma .g 3692 to 4072 1 to 381       381/384
(99 %)
1 diff
(99.8 %id)
AL525259 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 3697 to 4657 969 to 1       969/970
(99 %)
68 diff
(93.0 %id)
AA745149 Ewing's sarcoma .g 3715 to 4117 1 to 409       409/409
(100 %)
59 diff
(85.6 %id)
BE702352 nervous_normal .g 3739 to 4027 1 to 289       289/289
(100 %)
0 diff
(100 %id)
BM927456 lymph, lymphoma, cell line .g 3747 to 4696 1 to 961       961/1103
(87 %)
26 diff
(97.7 %id)
BQ065822 lymph, lymphoma, cell line .g 3747 to 4674 1 to 941       941/1009
(93 %)
30 diff
(97.1 %id)
BQ066216 lymph, lymphoma, cell line .g 3747 to 4694 1 to 970   tiling clone, AAA   970/970
(100 %)
33 diff
(96.6 %id)
D31439   .g 3751 to 4079 1 to 331       331/331
(100 %)
6 diff
(98.2 %id)
AW406504 lymph .g 3762 to 4257 18 to 513       496/513
(96 %)
6 diff
(98.9 %id)
TI_154144114   .g 3762 to 4463 88 to 799   AAA   712/730
(97 %)
21 diff
(97.2 %id)
BE257181 eye, retinoblastoma .g 3765 to 4401 1 to 635       635/636
(99 %)
6 diff
(99.1 %id)
BG396362 eye, retinoblastoma .g 3784 to 4566 1 to 772       772/824
(93 %)
15 diff
(98.2 %id)
AA625454 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 3799 to 4382 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
CB052287 leiomyosarcoma, soft tissue .g 3801 to 4009 10 to 218       209/218
(95 %)
6 diff
(97.3 %id)
BM715373 eye, human retina .g 3807 to 4285 1 to 475   fully sequenced,   475/475
(100 %)
0 diff
(100 %id)
TI_153965277   .g 3807 to 4690 108 to 981   AAA   874/874
(100 %)
44 diff
(95.0 %id)
CB123158 Liver .g 3812 to 4215 1 to 404       404/404
(100 %)
0 diff
(100 %id)
BU608070 Human Lung Epithelial cells, lung .g 3843 to 4549 1 to 713     Submitted on the opposite strand 713/713
(100 %)
9 diff
(98.8 %id)
TI_154111710   .g 3844 to 4693 936 to 89   AAA   848/949
(89 %)
7 diff
(99.3 %id)
CA450400 Human Lung Epithelial cells, lung .g 3844 to 4316 1 to 480     Submitted on the opposite strand 480/480
(100 %)
14 diff
(97.1 %id)
BM716031 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 3847 to 4209 17 to 380       364/380
(95 %)
6 diff
(98.5 %id)
GD157634   .g 3858 to 4016 158 to 1   AAA Submitted on the opposite strand 158/165
(95 %)
4 diff
(97.6 %id)
BM738616 stomach .g 3871 to 4501 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BM746562 stomach .g 3871 to 4430 1 to 561       561/561
(100 %)
3 diff
(99.5 %id)
BX393257   .g 3876 to 4683 816 to 9       808/899
(89 %)
0 diff
(100 %id)
AW027096 thymus, pooled .g 3878 to 4429 1 to 552     Submitted on the opposite strand 552/552
(100 %)
5 diff
(99.1 %id)
TI_149297621   .g 3883 to 4696 59 to 865     Submitted on the opposite strand 807/1062
(75 %)
19 diff
(98.3 %id)
CB850655 lung, Primary Lung Cystic Fibrosis EpithelialCells .g 3883 to 4574 10 to 701     Submitted on the opposite strand 692/701
(98 %)
6 diff
(99.2 %id)
BU859475 ovary, teratocarcinoma, cell line .g 3890 to 4696 826 to 12     Submitted on the opposite strand 815/911
(89 %)
0 diff
(100 %id)
BE794794 lung, small cell carcinoma .g 3894 to 3986 598 to 693       650/887
(73 %)
22 diff
(97.6 %id)
BQ670947 epidermoid carcinoma, cell line, salivary gland .g 3895 to 4665 13 to 785       773/945
(81 %)
14 diff
(98.6 %id)
BM727920 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 3896 to 4278 30 to 413   fully sequenced,   384/413
(92 %)
1 diff
(99.8 %id)
TI_149311130   .g 3900 to 4693 868 to 82   AAA   787/934
(84 %)
35 diff
(96.3 %id)
BE393109 endometrium, adenocarcinoma cell line, uterus .g 3910 to 4553 1 to 637       637/727
(87 %)
11 diff
(98.5 %id)
CA426759 cell lines, Chondrosarcoma .g 3946 to 4693 761 to 15   AAA   747/747
(100 %)
2 diff
(99.8 %id)
BM832369 stomach .g 3971 to 4374 1 to 404       404/404
(100 %)
0 diff
(100 %id)
TI_149282013   .g 3973 to 4693 797 to 79   AAA   719/720
(99 %)
4 diff
(99.5 %id)
TI_154048663   .g 3979 to 4693 793 to 82   AAA   712/724
(98 %)
16 diff
(97.8 %id)
CN478856 Human Lung Epithelial cells, lung .g 3981 to 4693 728 to 15   AAA   714/714
(100 %)
1 diff
(99.9 %id)
CN372780 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 3987 to 4586 12 to 610       599/610
(98 %)
6 diff
(99.1 %id)
BU192393 embryonal carcinoma, cell line, testis .g 3991 to 4459 469 to 1     Submitted on the opposite strand 469/918
(51 %)
5 diff
(99.5 %id)
BQ083081 Ascites, stomach .g 4005 to 4395 1 to 391       391/391
(100 %)
1 diff
(99.8 %id)
BX342091   .g 4027 to 4634 610 to 1       610/991
(61 %)
19 diff
(98.1 %id)
CR597964 Neuroblastoma Cot 25-normalized .g 4046 to 4696 1 to 651       651/651
(100 %)
0 diff
(100 %id)
BX345509 Neuroblastoma Cot 25-normalized .g 4046 to 4696 1 to 651   fully sequenced,   651/651
(100 %)
1 diff
(99.9 %id)
BM983599 lung .g 4046 to 4693 661 to 15   AAA   647/647
(100 %)
3 diff
(99.6 %id)
BQ448705 Knee, Osteoarthritic Cartilage .g 4063 to 4693 646 to 15   AAA   632/632
(100 %)
2 diff
(99.7 %id)
BF879830 lung_tumor .g 4066 to 4435 389 to 17     Submitted on the opposite strand 373/389
(95 %)
12 diff
(97.0 %id)
BF823637 kidney_tumor .g 4068 to 4484 420 to 4     Submitted on the opposite strand 417/420
(99 %)
0 diff
(100 %id)
BC018887.
matches multiple genes
choriocarcinoma, placenta, Placenta, choriocarcinoma .g 4074 to 4698 486 to 1110   available from MGC, AAA also hits gene SEC61G 625/1110
(56 %)
6 diff
(99.5 %id)
BC002848 Placenta, choriocarcinoma .g 4074 to 4698 495 to 1119   AAA   625/1119
(55 %)
6 diff
(99.5 %id)
BM450446 eye, retinoblastoma .g 4090 to 4695 1 to 606       606/710
(85 %)
1 diff
(99.9 %id)
BU846018 ovary, teratocarcinoma, cell line .g 4091 to 4696 616 to 10     Submitted on the opposite strand 607/1027
(59 %)
0 diff
(100 %id)
BM820668 Ascites, stomach .g 4097 to 4539 1 to 440       440/440
(100 %)
5 diff
(98.9 %id)
R78746 placenta .g 4100 to 4502 1 to 404       404/405
(99 %)
6 diff
(98.6 %id)
CA448525 Chondrosarcoma, Left Pelvis .g 4100 to 4693 609 to 15   AAA   595/595
(100 %)
1 diff
(99.9 %id)
BI085765 astrocytoma grade IV, cell line, brain .g 4103 to 4636 545 to 1   fully sequenced,   545/545
(100 %)
22 diff
(96.0 %id)
BQ003817 Chondrosarcoma, Left Pelvis .g 4108 to 4693 599 to 15   AAA   585/585
(100 %)
2 diff
(99.7 %id)
CA424713 cell lines, Chondrosarcoma .g 4113 to 4693 595 to 15   AAA   581/581
(100 %)
0 diff
(100 %id)
BQ719132 sympathetic trunk .g 4121 to 4694 1 to 576       576/580
(99 %)
3 diff
(99.5 %id)
BQ901061 sympathetic trunk .g 4121 to 4690 1 to 570       570/571
(99 %)
1 diff
(99.9 %id)
AA334395   .g 4132 to 4347 13 to 228       216/228
(94 %)
6 diff
(97.4 %id)
BU621418 cell lines, Chondrosarcoma .g 4133 to 4693 579 to 19   AAA   561/561
(100 %)
2 diff
(99.7 %id)
BU689192 lung .g 4136 to 4693 573 to 15   AAA   559/559
(100 %)
6 diff
(99.0 %id)
BU683237 lung .g 4139 to 4689 569 to 19   AAA   551/554
(99 %)
5 diff
(99.1 %id)
BQ109567 pooled brain, lung, testis .g 4153 to 4696 1 to 544       544/550
(98 %)
1 diff
(99.9 %id)
EC450946 Prostate .g 4158 to 4271 114 to 1       114/114
(100 %)
0 diff
(100 %id)
EC509589 Prostate .g 4158 to 4271 112 to 1       112/112
(100 %)
3 diff
(97.4 %id)
EC538564 Prostate .g 4158 to 4271 113 to 1       113/113
(100 %)
2 diff
(98.3 %id)
EC568208 Prostate .g 4159 to 4261 112 to 14       99/112
(88 %)
0 diff
(100 %id)
BI087622 cervix .g 4187 to 4692 1 to 506   AAA   506/506
(100 %)
7 diff
(98.7 %id)
BP387367 pancreatic islet .g 4223 to 4693 1 to 471     Submitted on the opposite strand 471/471
(100 %)
0 diff
(100 %id)
AA835890 germinal center B cell .g 4231 to 4696 471 to 7       465/471
(98 %)
0 diff
(100 %id)
AI476588 pooled .g 4242 to 4691 450 to 1       450/450
(100 %)
6 diff
(98.7 %id)
BF801152 colon_ins .g 4245 to 4635 394 to 9     Submitted on the opposite strand 386/394
(97 %)
0 diff
(100 %id)
BU742447 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 4248 to 4693 460 to 15   fully sequenced, AAA   446/446
(100 %)
1 diff
(99.8 %id)
AA766778 germinal center B cell .g 4251 to 4689 445 to 12   AAA   434/438
(99 %)
11 diff
(97.5 %id)
BM665154 eye, human retina .g 4255 to 4693 453 to 15   fully sequenced, AAA   439/439
(100 %)
0 diff
(100 %id)
CR974629 T-Lymphocytes .g 4256 to 4689 9 to 449       441/450
(98 %)
11 diff
(97.6 %id)
BM855827 stomach .g 4257 to 4468 1 to 212       212/212
(100 %)
5 diff
(97.7 %id)
AA722036 pineal gland .g 4260 to 4690 430 to 1       430/430
(100 %)
2 diff
(99.6 %id)
BU739776 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 4263 to 4694 451 to 19   AAA   433/433
(100 %)
5 diff
(98.9 %id)
AI805946 pooled .g 4264 to 4692 432 to 4       429/432
(99 %)
0 diff
(100 %id)
D81456 brain .g 4267 to 4661 1 to 387       387/387
(100 %)
10 diff
(97.5 %id)
AA831626 germinal center B cell .g 4267 to 4696 435 to 7       429/441
(97 %)
0 diff
(100 %id)
CX866043 embryonic stem .g 4269 to 4693 458 to 34   AAA   425/425
(100 %)
12 diff
(97.2 %id)
AA354247   .g 4273 to 4607 1 to 335       335/335
(100 %)
0 diff
(100 %id)
AA316149 colon .g 4280 to 4692 1 to 413       413/413
(100 %)
1 diff
(99.8 %id)
AW951953   .g 4281 to 4632 1 to 352       352/353
(99 %)
2 diff
(99.5 %id)
BU623560 cell lines, Enchondroma .g 4284 to 4689 425 to 19   AAA   407/407
(100 %)
11 diff
(97.3 %id)
AA479109 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 4285 to 4684 399 to 1       399/399
(100 %)
5 diff
(98.8 %id)
CA413396 Knee, Osteoarthritic Cartilage .g 4285 to 4693 421 to 15   AAA   407/407
(100 %)
2 diff
(99.6 %id)
BQ447788 Knee, Osteoarthritic Cartilage .g 4285 to 4693 424 to 15   AAA   410/410
(100 %)
1 diff
(99.8 %id)
AI351360 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 4287 to 4693 407 to 1       407/407
(100 %)
1 diff
(99.8 %id)
AI199662 anaplastic oligodendroglioma, brain .g 4289 to 4699 412 to 2   tiling clone,   411/412
(99 %)
0 diff
(100 %id)
BE676266 B-cell, chronic lymphotic leukemia .g 4289 to 4691 403 to 1       403/403
(100 %)
1 diff
(99.8 %id)
BX108742 whole brain .g 4291 to 4693 417 to 15   AAA   403/403
(100 %)
3 diff
(99.3 %id)
AA758249 pineal gland .g 4302 to 4689 387 to 1       387/387
(100 %)
4 diff
(99.0 %id)
AI275881 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 4303 to 4696 394 to 1       394/394
(100 %)
1 diff
(99.8 %id)
AI281029 adenocarcinoma, colon .g 4305 to 4693 389 to 1       389/389
(100 %)
1 diff
(99.8 %id)
AI274136 adenocarcinoma, colon .g 4305 to 4693 389 to 1       389/389
(100 %)
2 diff
(99.5 %id)
AI421462 brain, glioblastoma (pooled) .g 4317 to 4689 386 to 14   AAA   373/373
(100 %)
2 diff
(99.5 %id)
BE349016 malignant melanoma, metastatic to lymphnode, skin .g 4317 to 4695 378 to 1       378/378
(100 %)
6 diff
(98.5 %id)
BE300929 Burkitt lymphoma, lymph .g 4324 to 4696 373 to 1       373/373
(100 %)
3 diff
(99.2 %id)
R41320 whole brain .g 4334 to 4696 378 to 7       372/379
(98 %)
0 diff
(100 %id)
AI302519 2 pooled tumors (clear cell type), Kidney .g 4335 to 4689 372 to 18   AAA   355/355
(100 %)
1 diff
(99.8 %id)
AI991274 colon, colonic mucosa from 3 patients with Crohn'sdisease .g 4336 to 4690 356 to 1       356/430
(82 %)
3 diff
(99.4 %id)
BM709068 eye, optic nerve .g 4343 to 4693 1 to 351   fully sequenced, AAA   351/351
(100 %)
0 diff
(100 %id)
AI582427 adenocarcinoma, Pancreas .g 4345 to 4696 352 to 1       352/352
(100 %)
2 diff
(99.5 %id)
DB519130 testis .g 4350 to 4693 1 to 344     Submitted on the opposite strand 344/344
(100 %)
3 diff
(99.2 %id)
AI472935 pooled .g 4358 to 4692 339 to 5       335/339
(98 %)
0 diff
(100 %id)
AW079407 colon, moderately differentiated adenocarcinoma .g 4360 to 4693 330 to 1       330/330
(100 %)
4 diff
(98.8 %id)
R00886 liver and spleen .g 4386 to 4678 295 to 1       295/306
(96 %)
9 diff
(97.1 %id)
AA757527 pineal gland .g 4388 to 4648 260 to 1       260/260
(100 %)
5 diff
(98.1 %id)
AI244572 Kidney .g 4395 to 4694 298 to 1       298/298
(100 %)
17 diff
(94.3 %id)
BY797479 eye .g 4398 to 4694 1 to 297       297/297
(100 %)
0 diff
(100 %id)
AI689075 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 4402 to 4693 320 to 29   AAA   292/292
(100 %)
4 diff
(98.7 %id)
C02104   .g 4443 to 4554 10 to 120       111/120
(92 %)
5 diff
(95.9 %id)
AI350905 pooled germ cell tumors .g 4460 to 4696 239 to 3       237/323
(73 %)
0 diff
(100 %id)
AI949048 pooled germ cell tumors .g 4460 to 4696 239 to 3       237/324
(73 %)
0 diff
(100 %id)
BX345508 Neuroblastoma Cot 25-normalized .g 4497 to 4675 179 to 1   fully sequenced,   179/179
(100 %)
0 diff
(100 %id)
BU732531 eye, optic nerve .g 4503 to 4693 209 to 19   fully sequenced, AAA   191/191
(100 %)
0 diff
(100 %id)
AW051071 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 4505 to 4693 191 to 1       191/191
(100 %)
2 diff
(99.0 %id)
BU587340 mixed (pool of 40 RNAs) .g 4516 to 4694 1 to 179   AAA   179/179
(100 %)
2 diff
(98.9 %id)
AW452636   .g 4536 to 4693 175 to 18   AAA   158/164
(96 %)
2 diff
(98.8 %id)
AA706413   .g 4545 to 4693 160 to 12   AAA   149/149
(100 %)
0 diff
(100 %id)
BE242367 leukopheresis .g 4572 to 4687 115 to 1       115/115
(100 %)
4 diff
(96.6 %id)
BE246730 leukopheresis .g 4620 to 4689 70 to 1       70/94
(74 %)
0 diff
(100 %id)
BC034409 Brain, Lung, Testis, adult, pooled whole .h 1 to 2052 4 to 2054 exact tiling clone, available from MGC, AAA   2054/2054
(100 %)
2 diff
(100.0 %id)
BM713265 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .i 1 to 578 1 to 578   tiling clone, fully sequenced,   578/578
(100 %)
0 diff
(100 %id)
BE395527 endometrium, adenocarcinoma cell line, uterus .i 13 to 558 1 to 546       546/546
(100 %)
0 diff
(100 %id)
BF030226 hypernephroma, Kidney .i 16 to 697 1 to 675       677/892
(75 %)
22 diff
(97.6 %id)
BQ640015 eye, retina .i 44 to 501 1 to 458       458/458
(100 %)
3 diff
(99.4 %id)
BM809412 amelanotic melanoma, cell line, skin .i 59 to 764 17 to 723       707/794
(89 %)
12 diff
(98.5 %id)
BM726266 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .i 60 to 415 1 to 356   fully sequenced,   356/356
(100 %)
0 diff
(100 %id)
BM809390 amelanotic melanoma, cell line, skin .i 64 to 915 20 to 875   tiling clone, AAA   856/875
(97 %)
17 diff
(98.1 %id)
BM555459 amelanotic melanoma, cell line, skin .i 64 to 915 23 to 878       856/883
(96 %)
21 diff
(97.7 %id)
BP334330 salivary gland .i 82 to 656 1 to 581       578/583
(99 %)
5 diff
(99.2 %id)
TI_159707163   .i 88 to 915 914 to 96   AAA   819/1001
(81 %)
32 diff
(96.9 %id)
BE883008 leiomyosarcoma, uterus .i 90 to 817 1 to 728       728/729
(99 %)
13 diff
(98.3 %id)
AA478647 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 117 to 664 1 to 542   fully sequenced,   542/542
(100 %)
7 diff
(98.8 %id)
BX100113 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 118 to 882 1 to 765       765/765
(100 %)
0 diff
(100 %id)
AA482376 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 124 to 415 1 to 294   fully sequenced,   292/292
(100 %)
28 diff
(90.5 %id)
AI346929 adenocarcinoma, colon .i 141 to 915 789 to 15   AAA   775/778
(99 %)
20 diff
(97.5 %id)
BG746058 Spleen .i 149 to 850 739 to 18       722/1069
(67 %)
38 diff
(96.5 %id)
BQ446829 Knee, Osteoarthritic Cartilage .i 155 to 915 778 to 19   AAA   760/760
(100 %)
1 diff
(99.9 %id)
BG338694 leiomyosarcoma cell line, uterus .i 167 to 866 1 to 694       694/912
(76 %)
17 diff
(98.2 %id)
CR977633 T-Lymphocytes .i 189 to 917 1 to 729       729/729
(100 %)
2 diff
(99.8 %id)
BX431709 T cells (Jurkat cell line) .i 203 to 917 1 to 714   tiling clone,   714/714
(100 %)
3 diff
(99.6 %id)
AW242056 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .i 234 to 915 700 to 17   AAA   684/739
(92 %)
42 diff
(94.4 %id)
AI797808 B-cell, chronic lymphotic leukemia .i 244 to 917 677 to 4       674/677
(99 %)
6 diff
(99.2 %id)
AW182507 pooled .i 259 to 917 658 to 2       657/669
(98 %)
7 diff
(99.0 %id)
AI762789 B-cell, chronic lymphotic leukemia .i 263 to 915 660 to 11   AAA   650/650
(100 %)
8 diff
(98.8 %id)
R73278 breast .i 282 to 562 1 to 284   fully sequenced,   284/284
(100 %)
6 diff
(97.9 %id)
W24327 senescent fibroblast .i 294 to 574 11 to 290   fully sequenced,   280/290
(96 %)
10 diff
(96.6 %id)
BM791999 Ascites, stomach .i 297 to 862 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
AA888096 colon, colon tumor RER+ .i 315 to 915 605 to 11   AAA   597/600
(99 %)
15 diff
(97.5 %id)
CB242061 Human Lung Epithelial cells, lung .i 343 to 915 591 to 19   AAA   573/573
(100 %)
3 diff
(99.5 %id)
AA417887 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 354 to 913 562 to 4   fully sequenced,   559/562
(99 %)
5 diff
(99.2 %id)
BM680875 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .i 361 to 915 573 to 19   fully sequenced, AAA   555/555
(100 %)
0 diff
(100 %id)
BM144983 leukopheresis .i 363 to 915 569 to 17   AAA   553/553
(100 %)
0 diff
(100 %id)
CK823013 Islets of Langerhans, Pancreas .i 375 to 915 560 to 20   AAA   541/541
(100 %)
1 diff
(99.9 %id)
AA533617 colon .i 385 to 913 533 to 1       533/537
(99 %)
53 diff
(90.2 %id)
AA534401 colon .i 385 to 881 494 to 1       494/495
(99 %)
5 diff
(99.0 %id)
AI801680 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i 385 to 915 544 to 16   AAA   529/558
(94 %)
9 diff
(98.4 %id)
AW105047 pooled .i 385 to 915 532 to 1       532/541
(98 %)
3 diff
(99.5 %id)
AA904631 pooled .i 386 to 917 533 to 4       530/568
(93 %)
9 diff
(98.5 %id)
BQ102439 Islets of Langerhans, Pancreas .i 387 to 915 548 to 20   AAA   529/529
(100 %)
1 diff
(99.9 %id)
AA897625 pooled .i 388 to 917 530 to 3       528/637
(82 %)
19 diff
(97.1 %id)
AA744795 germinal center B cell .i 414 to 917 507 to 6       502/507
(99 %)
1 diff
(99.9 %id)
AA744796 germinal center B cell .i 414 to 892 476 to 1       476/476
(100 %)
9 diff
(98.2 %id)
TI_157604330   .i 415 to 915 606 to 106       501/610
(82 %)
21 diff
(96.6 %id)
AI350737 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 424 to 917 486 to 1       486/486
(100 %)
10 diff
(98.0 %id)
AI334019 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 426 to 915 524 to 35   AAA   490/490
(100 %)
22 diff
(95.6 %id)
AI352378 pooled germ cell tumors .i 434 to 917 486 to 3       484/486
(99 %)
2 diff
(99.6 %id)
AA974016 pooled germ cell tumors .i 437 to 915 481 to 1       481/481
(100 %)
10 diff
(98.0 %id)
TI_158433402   .i 438 to 915 575 to 90   AAA   486/1054
(46 %)
35 diff
(96.7 %id)
CF995468 Pooled Chondrosarcoma Tumor cells .i 445 to 918 85 to 559       475/1059
(44 %)
12 diff
(98.9 %id)
AI187045 lung .i 446 to 915 482 to 13   AAA   470/479
(98 %)
4 diff
(99.2 %id)
BQ010922 placenta .i 446 to 915 488 to 19   AAA   470/470
(100 %)
2 diff
(99.6 %id)
AU185786 skin .i 449 to 914 1 to 464       464/464
(100 %)
2 diff
(99.6 %id)
AI818597 adenocarcinoma, Pancreas .i 457 to 915 458 to 1       458/458
(100 %)
5 diff
(99.0 %id)
AJ706216 bone marrow .i 465 to 917 13 to 465       453/471
(96 %)
17 diff
(96.4 %id)
BM193619 leukopheresis .i 478 to 915 454 to 17   AAA   438/439
(99 %)
2 diff
(99.6 %id)
AI749602 aorta .i 482 to 915 432 to 1       432/437
(98 %)
11 diff
(97.5 %id)
AI309931 adenocarcinoma, colon .i 490 to 913 424 to 1       424/424
(100 %)
8 diff
(98.2 %id)
AW205690   .i 525 to 915 408 to 18   AAA   391/391
(100 %)
0 diff
(100 %id)
R72827 breast .i 532 to 915 385 to 1   fully sequenced,   385/385
(100 %)
1 diff
(99.8 %id)
BG222940 brain, glioblastoma without EGFR amplification .i 543 to 915 394 to 21   AAA   374/376
(99 %)
12 diff
(96.9 %id)
N95446 senescent fibroblast .i 544 to 915 380 to 15   fully sequenced, AAA   366/366
(100 %)
0 diff
(100 %id)
BM676382 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .i 548 to 915 386 to 19   fully sequenced, AAA   368/368
(100 %)
1 diff
(99.8 %id)
BF359806 marrow .i 562 to 812 257 to 7       251/257
(97 %)
3 diff
(98.9 %id)
BP386177 pancreatic islet .i 596 to 914 1 to 320     Submitted on the opposite strand 320/321
(99 %)
2 diff
(99.4 %id)
T84198 liver and spleen .i 599 to 917 1 to 326   fully sequenced,   326/326
(100 %)
9 diff
(97.3 %id)
AA479188 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 633 to 913 284 to 4   fully sequenced,   281/284
(98 %)
0 diff
(100 %id)
T88815 liver and spleen .i 756 to 906 150 to 1   fully sequenced,   150/150
(100 %)
1 diff
(99.4 %id)
BM729194 eye, fetal eye .j 1 to 595 1 to 594   tiling clone,   594/594
(100 %)
1 diff
(99.9 %id)
DB100627 testis .j 577 to 1168 2 to 593   tiling clone, capped   592/592
(100 %)
2 diff
(99.7 %id)
DT220247 brain .j 715 to 1292 1 to 582   tiling clone,   586/582
(100 %)
7 diff
(98.8 %id)
BE883887 leiomyosarcoma, uterus .j 757 to 1352 1 to 596   tiling clone,   596/596
(100 %)
0 diff
(100 %id)
BM682117 eye, fetal eye .j 980 to 1608 644 to 17   tiling clone, AAA   628/628
(100 %)
2 diff
(99.7 %id)
AK096830 Prostate .k 1 to 2301 2 to 2302 exact tiling clone, available from FLJ,   2302/2302
(100 %)
1 diff
(100.0 %id)
DA879493 Prostate .k 1 to 574 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA590449 lung .k 10 to 584 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA365090 subthalamic nucleus .k 216 to 765 2 to 551   capped   550/550
(100 %)
3 diff
(99.5 %id)
CN281389 embryonic stem cells, cell lines H1, H7, andH9 .k 302 to 776 1 to 476       476/476
(100 %)
6 diff
(98.8 %id)
TI_57196459   .k 315 to 1099 34 to 819       786/819
(95 %)
7 diff
(99.2 %id)
BC029904 Brain, Lung, Testis, adult, pooled whole .k 323 to 2299 1 to 1977 exact available from MGC, AAA   1977/1977
(100 %)
1 diff
(100.0 %id)
BI818565 pooled brain, lung, testis .k 323 to 1099 1 to 778   available from MGC,   778/778
(100 %)
2 diff
(99.8 %id)
NM_001103167.1   .k 323 to 2301 1 to 1979 exact RefSeq, AAA   1979/1979
(100 %)
0 diff
(100 %id)
BC044225 Brain, fetal, whole pooled .k 335 to 2299 1 to 1965 exact tiling clone, available from MGC, AAA   1965/1965
(100 %)
0 diff
(100 %id)
W95068 liver and spleen .k 1756 to 2301 561 to 1       558/561
(99 %)
29 diff
(94.9 %id)
DB330277 Prostate .k 1756 to 2301 547 to 1       547/547
(100 %)
1 diff
(99.9 %id)
DB542493 hippocampus .k 1851 to 2301 1 to 452     Submitted on the opposite strand 452/452
(100 %)
3 diff
(99.4 %id)
DB538852 hippocampus .k 1856 to 2301 1 to 445     Submitted on the opposite strand 445/445
(100 %)
6 diff
(98.7 %id)
AI923985 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .k 1877 to 2302 428 to 3       426/428
(99 %)
0 diff
(100 %id)
AA883401 pooled .k 1960 to 2301 339 to 1       339/339
(100 %)
3 diff
(99.2 %id)
AI858843 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .k 2018 to 2303 319 to 34   tiling clone, AAA   286/286
(100 %)
14 diff
(95.2 %id)
BC046121 Lung, Spleen, fetal, pooled .l 1 to 2489 1 to 2489 exact tiling clone, available from MGC, AAA   2489/2489
(100 %)
2 diff
(100.0 %id)
BI770337 pooled lung and spleen .l 2 to 817 1 to 812 A28P C29A W30G T31L L32C ... available from MGC,   812/820
(99 %)
7 diff
(99.2 %id)
TI_57180336   .l 2 to 817 36 to 847 A28P C29A W30G T31L L32C ...     812/855
(94 %)
12 diff
(98.6 %id)
TI_57197523   .l 29 to 882 25 to 871       847/877
(96 %)
21 diff
(97.7 %id)
BI820681 pooled brain, lung, testis .l 33 to 882 1 to 843   available from MGC,   843/849
(99 %)
16 diff
(98.2 %id)
BM804685 ovary (pool of 3) .l 87 to 840 114 to 876       763/1138
(67 %)
17 diff
(98.6 %id)
CR745622 carcinoid, lung .l 389 to 787 399 to 1     Submitted on the opposite strand 399/399
(100 %)
0 diff
(100 %id)
BX104157 carcinoid, lung .l 393 to 787 395 to 1     Submitted on the opposite strand 395/395
(100 %)
0 diff
(100 %id)
BQ677994 melanotic melanoma, cell line, skin .l 608 to 1533 931 to 1     Submitted on the opposite strand 931/1000
(93 %)
24 diff
(97.6 %id)
BQ682809 melanotic melanoma, cell line, skin .l 730 to 1536 831 to 10     Submitted on the opposite strand 822/952
(86 %)
0 diff
(100 %id)
BU167967 melanotic melanoma, cell line, skin .l 739 to 1533 808 to 1     Submitted on the opposite strand 808/924
(87 %)
27 diff
(97.1 %id)
BU183371 melanotic melanoma, cell line, skin .l 739 to 1533 808 to 1     Submitted on the opposite strand 808/878
(92 %)
22 diff
(97.5 %id)
BG028801 Bone, osteosarcoma, cell line .l 921 to 1569 642 to 1     Submitted on the opposite strand 642/642
(100 %)
14 diff
(97.9 %id)
TI_154181421   .l 1079 to 1916 901 to 70     Submitted on the opposite strand 832/926
(89 %)
23 diff
(97.6 %id)
CF122009 CNCAP(3)T-225 cell line, Prostate .l 1257 to 1923 666 to 1     Submitted on the opposite strand 666/666
(100 %)
0 diff
(100 %id)
CR979810 T-Lymphocytes .l 1290 to 1848 559 to 1     Submitted on the opposite strand 559/559
(100 %)
2 diff
(99.7 %id)
BE696599 colon .l 1357 to 1717 379 to 13       367/389
(94 %)
0 diff
(100 %id)
BG324377 Kidney, renal cell adenocarcinoma .l 1462 to 2210 1 to 749       749/931
(80 %)
21 diff
(97.8 %id)
FN084782 breast carcinoma .l 1545 to 1649 103 to 1     Submitted on the opposite strand 103/106
(97 %)
4 diff
(96.3 %id)
BI260283 cervical carcinoma cell line, cervix .l 1548 to 2254 1 to 709       709/709
(100 %)
7 diff
(99.1 %id)
BF848236 lung_normal .l 1600 to 1926 14 to 339       326/356
(91 %)
9 diff
(97.5 %id)
BQ086373 Islets of Langerhans, Pancreas .l 1618 to 2170 1 to 553       553/553
(100 %)
0 diff
(100 %id)
CK823014 Islets of Langerhans, Pancreas .l 1618 to 2212 1 to 595   tiling clone,   595/595
(100 %)
0 diff
(100 %id)
BQ101075 Islets of Langerhans, Pancreas .l 1618 to 2045 1 to 428   fully sequenced,   428/428
(100 %)
0 diff
(100 %id)
BF359802 marrow .l 1711 to 2126 1 to 416       416/416
(100 %)
15 diff
(96.4 %id)
AA555004 normal prostatic epithelial cells, Prostate .l 1770 to 2085 1 to 307       307/310
(99 %)
11 diff
(96.5 %id)
FN126826 breast carcinoma .l 1904 to 2000 99 to 1     Submitted on the opposite strand 99/99
(100 %)
2 diff
(98.0 %id)
BG333279 large cell carcinoma, lung .l 1922 to 2093 173 to 2     Submitted on the opposite strand 172/173
(99 %)
0 diff
(100 %id)
BG331450 large cell carcinoma, lung .l 1922 to 2093 173 to 2     Submitted on the opposite strand 172/173
(99 %)
0 diff
(100 %id)
BQ100786 Islets of Langerhans, Pancreas .l 2015 to 2489 494 to 20   fully sequenced, AAA   475/475
(100 %)
1 diff
(99.8 %id)
DT219482 brain .m 1 to 635 1 to 635   tiling clone,   635/635
(100 %)
1 diff
(99.9 %id)
BQ958408 epidermoid carcinoma, cell line, lung .m 70 to 929 1 to 863   tiling clone,   863/901
(95 %)
9 diff
(99.1 %id)
BP348137 brain .m 198 to 778 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BQ957421 carcinoma, cell line, Prostate .m 230 to 927 1 to 698   tiling clone, AAA   698/698
(100 %)
2 diff
(99.8 %id)
AK301071 Spleen .n 1 to 1091 9 to 1099 H3Y tiling clone,   1099/1099
(100 %)
3 diff
(99.8 %id)
DC389356 Spleen .n 1 to 585 9 to 594       594/594
(100 %)
4 diff
(99.4 %id)
BP229304 brain .o 1 to 571 7 to 576 H6L G7A P8R R10G R11V ... tiling clone,   576/583
(98 %)
6 diff
(99.0 %id)
BQ083112 Ascites, stomach .p 1 to 487 1 to 487   tiling clone,   487/487
(100 %)
6 diff
(98.8 %id)
DA753183   .p 96 to 655 2 to 561   tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
BE744826 adenocarcinoma cell line, ovary .p 143 to 889 1 to 744   tiling clone,   744/747
(99 %)
6 diff
(99.2 %id)
BG775214 carcinoma, cell line, Prostate .p 188 to 835 1 to 648   tiling clone, fully sequenced,   648/648
(100 %)
3 diff
(99.6 %id)
BG775846 carcinoma, cell line, Prostate .p 345 to 848 548 to 49   tiling clone, fully sequenced,   500/548
(91 %)
0 diff
(100 %id)
NM_001031734.2   .q 1 to 842 1 to 842 exact RefSeq, AAA   842/842
(100 %)
0 diff
(100 %id)
DA243025 brain .q 2 to 591 2 to 591 exact capped   590/590
(100 %)
2 diff
(99.7 %id)
DT219749 brain .q 2 to 615 1 to 614 T45S R46* tiling clone,   614/614
(100 %)
6 diff
(99.1 %id)
DA783150 brain .q 3 to 578 2 to 578 L42P T44D T45N R46Q F48V ... capped   577/577
(100 %)
1 diff
(99.9 %id)
BG831648 epithelioid carcinoma cell line, Pancreas .q 4 to 612 1 to 608 V17F L18C L19C Q20R A21L ...     608/608
(100 %)
6 diff
(99.1 %id)
BF237793 leiomyosarcoma cell line, uterus .q 7 to 758 1 to 746 V17F L18C L19C Q20R A21L ...     746/943
(79 %)
30 diff
(96.9 %id)
DA811036 brain .q 7 to 555 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
AK300568 Prostate .q 8 to 995 1 to 988 S7T tiling clone,   988/988
(100 %)
3 diff
(99.7 %id)
DA403264 thalamus .q 9 to 526 2 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
DA879441 Prostate .q 9 to 574 2 to 567 S7T capped   566/566
(100 %)
3 diff
(99.5 %id)
DA940558 Spleen .q 9 to 541 2 to 535   capped   534/535
(99 %)
5 diff
(99.1 %id)
BP217218 corpus callosum .q 10 to 591 1 to 582 V76A Q81R     582/582
(100 %)
2 diff
(99.7 %id)
BC010155 Pancreas, adenocarcinoma .q 10 to 840 1 to 832 V76R D77R R78P S79L G80R ... available from MGC, AAA   832/832
(100 %)
3 diff
(99.7 %id)
BM049032 carcinoma, cell line, Prostate .q 10 to 495 1 to 490       490/691
(70 %)
28 diff
(96.0 %id)
CB987987 Human Placenta, placenta .q 15 to 718 28 to 741       714/773
(92 %)
21 diff
(97.3 %id)
TI_57201030   .q 15 to 860 31 to 880       850/880
(96 %)
26 diff
(97.1 %id)
DA770842 brain .q 16 to 590 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA927674 small intestine .q 16 to 555 2 to 543   capped   540/542
(99 %)
2 diff
(99.7 %id)
BC063460 Brain, Lung, Testis, adult, pooled whole .q 17 to 1004 1 to 988   tiling clone, available from MGC, AAA   988/988
(100 %)
1 diff
(99.9 %id)
CA391180 eye, RPE/choroid .q 17 to 491 1 to 475       475/475
(100 %)
0 diff
(100 %id)
BI823779 pooled brain, lung, testis .q 18 to 860 1 to 848       848/848
(100 %)
23 diff
(97.3 %id)
EL734941 mixed .q 20 to 570 1 to 551       551/644
(85 %)
7 diff
(99.0 %id)
DB125232 thymus .q 21 to 555 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
DR006282 Prostate .q 22 to 538 8 to 524       517/524
(98 %)
8 diff
(98.5 %id)
BE615408 adenocarcinoma, Pancreas .q 29 to 706 1 to 672   available from MGC,   672/672
(100 %)
12 diff
(98.3 %id)
TI_57151044   .q 32 to 805 29 to 798       770/798
(96 %)
13 diff
(98.4 %id)
CN368341 embryonic stem cells, DMSO-treated H9 cellline .q 34 to 806 9 to 783       775/783
(98 %)
4 diff
(99.5 %id)
BI762440 pooled colon, kidney, stomach .q 35 to 805 1 to 768       768/768
(100 %)
8 diff
(99.0 %id)
BE884857 leiomyosarcoma, uterus .q 38 to 706 1 to 662       662/829
(79 %)
19 diff
(97.8 %id)
DB470647 hippocampus .q 49 to 544 1 to 493       493/493
(100 %)
5 diff
(99.0 %id)
DB473724 hippocampus .q 49 to 511 1 to 460       460/460
(100 %)
2 diff
(99.6 %id)
AW248266 lung, small cell carcinoma .q 162 to 445 13 to 296   fully sequenced,   286/298
(95 %)
8 diff
(97.4 %id)
BU502474 carcinoma, cell line, Prostate .q 162 to 845 78 to 767       692/1029
(67 %)
25 diff
(97.6 %id)
CA426430 cell lines, Chondrosarcoma .q 162 to 840 696 to 17   AAA   680/687
(98 %)
2 diff
(99.8 %id)
BI667562 brain, hypothalamus .q 163 to 838 6 to 678   AAA   673/678
(99 %)
13 diff
(98.1 %id)
TI_44343521   .q 163 to 838 128 to 800   AAA   673/800
(84 %)
13 diff
(98.4 %id)
CA421861 Bone, Enchondroma cell line .q 165 to 841 694 to 19   AAA   676/696
(97 %)
1 diff
(99.9 %id)
BI823913 pooled brain, lung, testis .q 168 to 840 1 to 674       674/743
(90 %)
5 diff
(99.4 %id)
BF036698 adenocarcinoma, ovary .q 200 to 836 1 to 636       636/636
(100 %)
7 diff
(98.9 %id)
AA569348 breast .q 209 to 841 630 to 1       630/630
(100 %)
6 diff
(99.1 %id)
AA235150 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q 324 to 637 1 to 310   fully sequenced,   310/310
(100 %)
5 diff
(98.4 %id)
AA824331   .q 325 to 840 516 to 4       513/521
(98 %)
0 diff
(100 %id)
AI017898 pooled .q 325 to 840 517 to 2       516/522
(98 %)
3 diff
(99.5 %id)
AI142747 pooled .q 325 to 840 511 to 1       511/513
(99 %)
8 diff
(98.5 %id)
AI670909 Kidney .q 325 to 842 519 to 2       518/524
(98 %)
1 diff
(99.9 %id)
AI769166 pooled .q 325 to 840 516 to 1       516/518
(99 %)
2 diff
(99.7 %id)
TI_157610286   .q 326 to 834 610 to 95       516/618
(83 %)
12 diff
(98.1 %id)
AA456904 germinal center B cell .q 334 to 520 1 to 187       187/187
(100 %)
3 diff
(98.4 %id)
AI023065 senescent fibroblast .q 344 to 840 497 to 6       492/497
(98 %)
0 diff
(100 %id)
AI283038 placenta .q 359 to 840 488 to 8       481/488
(98 %)
0 diff
(100 %id)
AW594572 pooled germ cell tumors .q 361 to 841 485 to 5       481/485
(99 %)
2 diff
(99.6 %id)
AI146696 uterus .q 383 to 840 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AW245043 lung, small cell carcinoma .q 384 to 842 469 to 11   fully sequenced, AAA   459/459
(100 %)
0 diff
(100 %id)
BQ011343 placenta .q 399 to 840 458 to 17   AAA   442/442
(100 %)
0 diff
(100 %id)
AW002373 pooled germ cell tumors .q 402 to 842 442 to 2       441/442
(99 %)
0 diff
(100 %id)
AI493502 anaplastic oligodendroglioma, brain .q 404 to 841 447 to 10       438/447
(97 %)
0 diff
(100 %id)
DB553692 hypothalamus .q 405 to 838 1 to 432     Submitted on the opposite strand 432/432
(100 %)
6 diff
(98.7 %id)
AI080260 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q 407 to 840 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AI952981 anaplastic oligodendroglioma, brain .q 408 to 841 444 to 11   AAA   434/434
(100 %)
0 diff
(100 %id)
BQ012432 placenta .q 408 to 842 453 to 19   AAA   435/435
(100 %)
0 diff
(100 %id)
AI671980 Kidney .q 413 to 840 429 to 2       428/447
(95 %)
0 diff
(100 %id)
AW189502 serous papillary carcinoma, high grade, 2pooled tumors, uterus .q 413 to 841 430 to 2       429/434
(98 %)
0 diff
(100 %id)
AW089797 ovary, tumor, 5 pooled (see description) .q 417 to 846 431 to 3       429/433
(99 %)
0 diff
(100 %id)
AI498122 anaplastic oligodendroglioma, brain .q 420 to 842 423 to 1       423/423
(100 %)
0 diff
(100 %id)
AW469786 pooled .q 430 to 842 413 to 1       413/413
(100 %)
6 diff
(98.6 %id)
BI908153 leukocyte .q 444 to 840 1 to 397   AAA   397/397
(100 %)
0 diff
(100 %id)
AA456853 germinal center B cell .q 602 to 840 241 to 2       240/407
(58 %)
0 diff
(100 %id)
AA235014 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q 607 to 841 233 to 1   fully sequenced,   233/233
(100 %)
2 diff
(99.2 %id)
CR994738 T-Lymphocytes .r 1 to 696 1 to 698 R182X tiling clone,   698/698
(100 %)
2 diff
(99.8 %id)
CV575284 cornea, eye .s 1 to 614 1 to 614 T21A tiling clone,   614/614
(100 %)
2 diff
(99.7 %id)
CX784368 human embryonic stem cells .t 1 to 742 1 to 742 exact tiling clone,   742/742
(100 %)
0 diff
(100 %id)
BE731453 choriocarcinoma, placenta .u 1 to 769 1 to 767 L17R R25G S26A G27A P28R ... tiling clone,   767/768
(99 %)
12 diff
(98.5 %id)
BE730869 choriocarcinoma, placenta .u 1 to 761 1 to 760 L17R R25G S26A G27A P28G ... tiling clone,   760/773
(98 %)
15 diff
(98.1 %id)
CR996047 T-Lymphocytes .va 1 to 470 1 to 471 G148W G149R L152P S153V H154S ... tiling clone,   471/471
(100 %)
1 diff
(99.8 %id)
DA865938 Prostate .vb 1 to 535 2 to 536 exact tiling clone, capped   535/535
(100 %)
1 diff
(99.9 %id)
DB329620 Prostate .vb 1389 to 1944 556 to 1   tiling clone,   556/556
(100 %)
1 diff
(99.9 %id)
AK097022 small intestine .vc 1 to 1957 1 to 1958   tiling clone, available from FLJ,   1958/1962
(99 %)
7 diff
(99.7 %id)
DA925454 small intestine .vc 2 to 591 2 to 593   capped   592/592
(100 %)
3 diff
(99.5 %id)
CB156263 brain .vc 5 to 670 1 to 667 M4H A5G A6R S7L M8H ... tiling clone,   667/667
(100 %)
1 diff
(99.9 %id)
DA061875 cerebellum .vc 6 to 570 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
T09025   .vc 1020 to 1423 1 to 405   tiling clone,   405/413
(98 %)
12 diff
(97.1 %id)
DB332117 small intestine .vc 1444 to 1957 519 to 5       515/519
(99 %)
1 diff
(99.9 %id)
CV815022 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .vd 1 to 688 6 to 693 exact tiling clone, AAA   693/693
(100 %)
0 diff
(100 %id)
BX089619 liver and spleen .ve 1 to 469 1 to 469 exact tiling clone,   469/469
(100 %)
3 diff
(99.4 %id)
BQ549070 insulinoma, Pancreas .ve 3 to 109 18 to 126       109/126
(86 %)
6 diff
(95.3 %id)
CK826281 insulinoma, Pancreas .ve 8 to 627 638 to 19   tiling clone, AAA   620/620
(100 %)
0 diff
(100 %id)
BQ548716 insulinoma, Pancreas .ve 57 to 627 589 to 19   AAA   571/571
(100 %)
0 diff
(100 %id)
CX870919 embryonic stem .vf 1 to 660 1 to 660 exact tiling clone,   660/660
(100 %)
0 diff
(100 %id)
CN372776 embryonic stem cells, DMSO-treated H9 cellline .vf 15 to 543 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BQ213219 melanotic melanoma, skin .vf 43 to 649 23 to 638       616/886
(69 %)
13 diff
(98.6 %id)
BQ271987 Pancreas, Purified pancreatic islet .vg 1 to 573 1 to 573 exact tiling clone,   573/573
(100 %)
2 diff
(99.7 %id)
AI676136 Prostate .vg 177 to 660 484 to 1       484/484
(100 %)
2 diff
(99.6 %id)
AI203065 pooled germ cell tumors .vg 182 to 660 485 to 7       479/490
(97 %)
1 diff
(99.8 %id)
TI_57235524   .vg 266 to 652 32 to 434   AAA   403/434
(92 %)
3 diff
(99.4 %id)
BQ011013 placenta .vg 270 to 660 407 to 17   AAA   391/391
(100 %)
1 diff
(99.8 %id)
AW136071   .vg 271 to 661 408 to 18   AAA   391/391
(100 %)
1 diff
(99.8 %id)
AA939022 carcinoid, lung .vg 273 to 661 385 to 1       385/385
(100 %)
6 diff
(98.5 %id)
AI767766 2 pooled tumors (clear cell type), Kidney .vg 285 to 660 379 to 4       376/386
(97 %)
0 diff
(100 %id)
BF762311 colon_est .vg 286 to 636 1 to 351       351/351
(100 %)
3 diff
(99.2 %id)
AI203053 pooled germ cell tumors .vg 287 to 660 379 to 7       373/379
(98 %)
0 diff
(100 %id)
BF763258 colon_est .vg 297 to 636 340 to 1     Submitted on the opposite strand 340/344
(98 %)
0 diff
(100 %id)
AW237209 pooled germ cell tumors .vg 324 to 662 339 to 1       339/339
(100 %)
0 diff
(100 %id)
AI863798 colon, colon tumor, RER+ .vg 416 to 662 262 to 17   AAA   246/246
(100 %)
5 diff
(98.0 %id)
AI652779 pooled germ cell tumors .vg 423 to 660 268 to 30   AAA   239/239
(100 %)
9 diff
(96.3 %id)
CB049063 Prostate .vg 450 to 665 9 to 224   tiling clone, AAA   216/224
(96 %)
0 diff
(100 %id)
AI289404 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vg 459 to 665 226 to 20   AAA   207/207
(100 %)
0 diff
(100 %id)
BQ271665 Pancreas, Purified pancreatic islet .vg 636 to 978 343 to 1   tiling clone,   343/343
(100 %)
0 diff
(100 %id)
BP295982   .vh 1 to 582 1 to 582 exact tiling clone,   582/582
(100 %)
0 diff
(100 %id)
DA056459 cerebellum .vi 1 to 560 2 to 561 exact tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
BX092511 liver and spleen .vi 226 to 884 670 to 12 exact tiling clone, Submitted on the opposite strand 659/670
(98 %)
2 diff
(99.8 %id)
DC390526 Spleen .vj 1 to 562 1 to 562   tiling clone,   562/563
(99 %)
7 diff
(98.8 %id)
DC429105   .vj 22 to 607 1 to 586 exact tiling clone,   586/586
(100 %)
1 diff
(99.9 %id)
DA922388 small intestine .vk 1 to 583 2 to 584 exact tiling clone, capped   583/583
(100 %)
0 diff
(100 %id)
BF899044 marrow .vl-u 1 to 244 30 to 272 P4H H5T C6A D7T L8W ... tiling clone,   243/283
(85 %)
8 diff
(97.2 %id)
BF899038 marrow .vl-u 11 to 244 1 to 235   tiling clone,   235/246
(95 %)
6 diff
(97.6 %id)
BF899958 marrow .vl-u 17 to 244 26 to 251       226/262
(86 %)
7 diff
(97.4 %id)
BC037428 Uterus, leiomyosarcoma Gene ICAM3_, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
59 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk, .vl-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI